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ABSTRACT 
 
Polycyclic aromatic hydrocarbons (PAH) are a class of environmental pollutants 
consisting of a minimum of two fused aromatics rings originating from the incomplete 
combustion of organic matter and/or anthropogenic sources. Numerous possible anthropogenic 
and natural sources make the presence of PAH ubiquitous in the environment. The carcinogenic 
nature of some PAH and their ubiquitous presence makes their chemical analysis a topic of 
environmental and toxicological importance. Although environmental monitoring of PAH is an 
important step to prevent exposure to contaminated sites, it provides little information on the 
actual uptake and subsequent risks. Parent PAH are relatively inert and need metabolic activation 
to express their carcinogenicity. Covalent binding to DNA appears to be the first critical step in 
the initiation of the tumor formation process.  
To this end, the determination of short term biomarkers – such as monohydroxy-PAH 
metabolites (OH-PAH) - fills an important niche to interpret actual PAH exposure levels, prevent 
extreme body burdens and minimize cancer risk. One would certainly prefer an early warning 
parameter over a toxicological endpoint – such as DNA-adducts – indicating that extensive 
damage has already been done. Several methods have been developed to determine OH-PAH in 
specific tissue or excreta and food samples. The general trend for the analysis of OH-PAH 
follows the pattern of sample collection, sample clean-up and pre-concentration, 
chromatographic separation and quantification. Popular approaches for sample clean-up and pre-
concentration include liquid-liquid extraction (LLE) and solid-phase extraction (SPE). 
Chromatographic separation and quantification has been based on high-performance liquid 
iv 
 
chromatography-room temperature fluorescence detection (HPLC) and gas chromatography-
mass spectrometry (GC-MS). 
Although chromatographic techniques provide reliable results in the analysis of OH-
PAH, their experimental procedures are time consuming and expensive. Elution times of 30-60 
minutes are typical and standards must be run periodically to verify retention times. If the 
concentrations of target species are found to lie outside the detector’s response range, the sample 
must be diluted and the process repeated. On the other end of the concentration range, many 
samples are “zeroes,” i.e. the concentrations are below detection limits. Additional problems 
arise when laboratory procedures are scaled up to handle thousands of samples under mass 
screening conditions. Under the prospective of a sustainable environment, the large usage of 
organic solvents is one of the main limitations of the current chromatographic methodology.   
This dissertation focuses on the development of a screening methodology for the analysis 
of OH-PAH in urine and milk samples. Screening techniques capable of providing a “yes or no” 
answer to OH-PAH contamination prevent unnecessary scrutiny of un-contaminated samples via 
conventional methods, reduce analysis cost and expedite the turnaround time for decision 
making purposes. The proposed methodology is based on capillary zone electrophoresis (CZE) 
and synchronous fluorescence spectroscopy (SFS). Metabolites extraction and pre-concentration 
is achieved with optimized SPE, LLE and/or QuEChERS (quick, easy, cheap, effective, rugged 
and safe) procedures. The small sample and extracting solvent volumes facilitate the 
simultaneous extraction of numerous samples via an environmentally friendly procedure, which 
is well-suited for routine monitoring of numerous samples. Sample stacking is successfully 
implemented to improve CZE limits of detection by two orders of magnitude. The unique 
electrophoretic pattern of positional isomers of OH-PAH demonstrates the potential of CZE for 
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the unambiguous determination of metabolites with similar chromatographic behaviors and 
virtually similar fragmentation patterns. The direct determination of OH-PAH without 
chromatographic separation is demonstrated via SFS. The non-destructive nature of SFS 
provides ample opportunity for further metabolite confirmation via chromatographic techniques. 
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CHAPTER 1. INTRODUCTION 
 
1.1 Relevance of Polycyclic Aromatic Hydrocarbons and their Metabolites 
Polycyclic aromatic hydrocarbons (PAH) are a class of environmental pollutants 
consisting of a minimum of two fused aromatics rings originating from the incomplete 
combustion of organic matter and/or anthropogenic sources. Numerous possible anthropogenic 
and natural sources make the presence of PAH ubiquitous in the environment. The carcinogenic 
nature of some PAH and their ubiquitous presence make their chemical analysis a topic of 
environmental and toxicological importance.
1-3
 
As a tentative means of reducing human exposure to contaminated samples, the US 
Environmental Protection Agency (EPA) includes sixteen PAH in its priority pollutants list and 
recommends their routine monitoring in environmental samples.
4
 The list includes the following 
PAH: naphthalene, acenaphthylene, acenaphthene, fluorene, phenanthrene, fluoranthene, pyrene, 
chrysene, anthracene, benzo[g,h,i]perylene, dibenz[a,h]anthracene, benzo[a]anthracene, 
benzo[k]fluoranthene, benzo[b]fluoranthene, benzo[a]pyrene and  indeno[1,2,3-cd]-pyrene. 
Their molecular structures are shown in Figure 1.1. 
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Figure 1.1 Molecular structures of the 16 PAH in the EPA priority list.  
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Although environmental monitoring of PAH is an important step to prevent exposure to 
contaminated sites, it provides little information on the actual uptake and subsequent risks. PAH 
are introduced in the body by adsorption through the skin, ingestion or inhalation and can be 
subsequently metabolized to their monohydroxylated (OH-PAH) form. Due to the short average 
lifetime of OH-PAH elimination from the body, their quantitative determination in biological 
fluids such as urine, milk and blood samples provides accurate information on recent exposure to 
environmental PAH.
5
 
Parent PAH present different degrees of toxicity but they need metabolic activation to 
express their carcinogenicity. The biotransformation process consists of two phases. In phase I 
metabolism, PAH are oxidized by the cytochrome P450 enzymes to form reactive epoxide 
intermediates, followed by reduction or hydrolysis to hydroxylated derivatives. In phase II 
metabolism, hydroxyl-PAH form glucoronate and sulfate conjugates to facilitate their excretion 
through urine, bile and feces.
6
 These biological processes lead to the formation of multiple 
metabolites including epoxide, dihydrodiols, OH-PAH and polyhydroxy-PAH. Covalent binding 
to DNA is believed to be the first critical step in the initiation of the tumor formation process.
7, 8
 
This is depicted in Figure 1.2 which shows the metabolic pathways of benzo[a]pyrene (B[a]P), 
which is the most carcinogenic compound in the EPA priority pollutants list.
9
 The metabolic 
pathways of B[a]P include the formation of diol epoxides and their subsequent binding to DNA 
to form the PAH-DNA adducts. These adducts can then be repaired, restoring the original 
healthy DNA, or they can originate mutant DNA leading to the formation and proliferation of 
tumors.
10, 11  
4 
 
 
Figure 1.2 Overview of B[a]P metabolism 
CYP: Cytochrome P450. Adapted from [6]. 
 
In the environment, PAH can be transformed in OH-PAH by a number of oxidation 
pathways such as photo-oxidation or chemical oxidation. Biological transformations can also 
generate OH-PAH as a result of incomplete or unsuccessful remediation of PAH contaminated 
sites by various microorganisms such as bacteria and fungi. These microorganisms can partially 
degrade PAH into different oxygenated forms with higher polarity, such as OH-PAH.  The 
greater mobility of polar PAH derivatives facilitates their migration and accumulation in soil and 
other surroundings via surface water and ground water 
12-14
. 
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Human exposure to PAH can originate from a wide range of occupational and non-
occupational activities. Air pollution appears to be higher in urban areas compared to rural areas 
due to automobile exhaust and industrial activity. Cigarette smoking and environmental tobacco 
smoke, such as side-stream and mainstream smokes are the other main causes of air exposure to 
PAH.
15, 16
 Soil contamination originates from PAH adsorbed onto particles which fall to the 
ground and become accumulated.
17
 Water contamination can be observed after PAH leaching 
from soil into water and from industrial wastewater. The ingestion of PAH contaminated food is 
considered the primary source of non-occupational human exposure.
18
 The risk of PAH ingestion 
is even higher after cooking meat and fish with wood or charcoal. Some cereals, crops and other 
vegetables also contain PAH.
19, 20
 Occupationally related exposure to PAH is higher among 
workers in specific industries such as aluminum smelting;
21
 coke-oven workers;
22
 diesel engine 
mechanics;
23
 taxi, bus and truck drivers;
23-25
 painters;
26
 tool-booth operators
27
 and traffic police 
officers.
28
 
Not only humans can suffer the consequences of exposure to PAH in the environment, 
animals can also be affected by them. Water contamination can lead to PAH ingestion and 
adsorption by various aquatic creatures.
29
 Terrestrial animals can also be at risk of air-borne and 
aquatic PAH pollution. In addition, these animals can feed from grass or vegetables which grow 
in contaminated soil, especially if they are in heavily industrialized areas or in the proximity of 
highways.
30
 Since humans often feed on the exposed animals or consume their products and by-
products such as eggs or milk, dairy products can also pose a health hazard and constitute an 
important additional reason to monitoring animal exposure to PAH. 
6 
 
1.2 Chromatographic Analysis of PAH Metabolites 
Early methods 
5, 31, 32
 focused on the analysis of a few OH-PAH, with particular emphasis 
on 1-hydroxypyrene.
31
 Considering that human exposure often occurs to complex mixtures with 
numerous PAH, recent methods have expanded their scope to a larger number of metabolites.
33, 
34
 Particular attention has been paid to metabolites resulting from exposure to EPA-PAH, i.e. 
PAH included in the EPA priority pollutants list (see Figure 1.1).  
The general trend for the analysis of PAH metabolites in urine and milk samples follows 
the pattern of sample collection, sample clean-up and pre-concentration, chromatographic 
separation and quantification. Urine analysis of OH-PAH includes an additional hydrolysis step 
– which can be either enzymatic or acidic –to dissociate OH-PAH from their glucuronide and/or 
sulfate conjugates.
35
 Popular approaches for sample clean-up and pre-concentration include 
liquid-liquid extraction (LLE)
36
 and SPE.
37
 Both methodologies are well suited to automation, 
which increases sample throughput and reduces variability due to manual sample handling. 
Chromatographic separation and quantification has been based on high-performance liquid 
chromatography-room temperature fluorescence detection (HPLC)
38-40
 and gas chromatography-
mass spectrometry (GC-MS).
22, 34, 41, 42
 
Table 1 summarizes several features of previously reported methods for the 
chromatographic analysis of OH-PAH in urine samples. The tabulated information only includes 
the metabolites investigated in this dissertation, namely 2-hydroxyfluorene (2OH-Flu), 2-
hydroxynaphthalene (2OH-Naph), 1-hydroxypyrene (1OH-Pyr), 9-hydroxyphenanthrene (2OH-
Phen), 3-hydroxybenzo[a]pyrene (3OH-B[a]P), 4-hydroxybenzo[a]pyrene (4OH-B[a]P) and 5-
7 
 
hydroxybenzo[a]pyrene (5OH-B[a]P). No literature reports were found on the analysis of 4-
hydroxybenzo[a]pyrene and 5-hydroxybenzo[a]pyrene in urine samples. 
Numerous HPLC and GC-MS methods have been published for the analysis of OH-PAH 
metabolites in urine samples. Interesting to note is the wide range of recoveries reported for the 
metabolites under investigation.  Unfortunately, the standard deviations of the analytical 
recoveries were not reported, which make difficult the statistical comparison of the observed 
differences in their average values. Comparison of the analytical recoveries for those metabolites 
with reported values via the two methods reveals better recoveries via GC-MS for 2-
hydroxynaphthalene and 2-hydroxyfluorene. 9-hydroxyphenanthrene and 1-hydroxypyrene 
presented approximately the same recovery via HPLC and GC analysis. The best limits of 
detection (LOD) were clearly obtained via GCMS. Unfortunately GC-MS procedures are more 
complicated than HPLC methodology.
33, 34
 GC-MS requires a chemical derivatization step prior 
to metabolite separation to avoid peak tailing in the chromatographic column. 
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Table 1.1 Analytical figures of merit reported for OH-PAH analysis in urine samples by HPLC and GC-MS 
Metabolite 
LOD 
(ng/L) 
Recovery  
(%) 
Sample Preparation 
Instrumental 
method 
Analysis time 
(min)
a)
 
Reference 
2-hydroxynaphthalene 730 82 SPE, evap. HPLC 40 
40 
2-hydroxynaphthalene 10.5 99 SPE, evap., derivatization GC-MS 24 
33 
2-hydroxyfluorene 727 62 SPE, evap. HPLC 40 
40 
2-hydroxyfluorene 3.6 82 SPE, evap., derivatization GC-MS 27 
34 
9-hydroxyphenanthrene 165 57 SPE, evap. HPLC 40 
40 
9-hydroxyphenanthrene 200 50 SPE, evap., derivatization GC-MS 40 
41 
1-hydroxypyrene 40 83 SPE, evap. HPLC 40 
40 
1-hydroxypyrene 44 68 SPE, evap. HPLC 40 
40 
1-hydroxypyrene 1.6 99 SPE, evap., derivatization GC-MS 24 
33 
1-hydroxypyrene 3.3 80 SPE, evap., derivatization GC-MS 27 
34 
3-hydroxybenzo[a]pyrene 1615 40 SPE, evap. HPLC 40 
40 
3-hydroxybenzo[a]pyrene 40 48 SPE, evap. HPLC 45 
23 
3-hydroxybenzo[a]pyrene 10.0 NA SPE, evap., derivatization GC-MS 27 
34 
a) Instrumental analysis only; does not include sample preparation procedures  
9 
 
Table 1.2 summarizes the pertinent features of HPLC and GC-MS methods previously 
reported for the analysis of OH-PAH in milk samples. Chromatographic analysis of milk samples 
have focused on the determination of 1-hydroxypyrene (1OH-PAH), 3-hydroxybenzo[a]pyrene 
(3OH-B[a]P), 2-hydroxyfluorene (2OH-Flu) and 1-, 2-, 3-, 4-, and 9-hydroxyphenanthrene 
(9OH-Phen). 
45-50
 Sample volumes varying from 5 to 50 mL have provided LODs ranging from 
0.04 ng.ml
-1
 (1OH-Pyr)
46
 to 5.1 ng.mL
-1 
(2OH-Flu).
47
. The main disadvantages of the reported 
methodology are the low recoveries (32 – 43%) and relatively long analyses times. Excluding the 
sample preparation steps, reported instrumental times, i.e. chromatographic elution times have 
varied from 26 to 70 min per sample. No literature reports were found on the analysis of 1-
hydroxynaphthalene and 2-hydroxynaphthalene in milk samples. The information on the 
recoveries of OH-PAH from milk samples is scarce and incomplete.  
10 
 
Table 1.2 Reported methods for the analysis of OH-PAH in milk samples by HPLC and GC-MS 
Metabolite LOD (ppb) 
Sample 
Volume (ml) 
a)
 
Recovery % Sample Preparation 
b)
 
Instrumental 
method 
Analysis time 
(min) 
c)
 
Reference 
1OH-Pyr NA 50 NA LLE, SPE, derivatization GC-MS 26 
49
 
3OH-B[a]P NA 50 NA LLE, SPE, derivatization GC-MS 26 
49
 
3OH-Phen NA 50 NA LLE, SPE, derivatization GC-MS 26 
49
 
2OH-Flu 2.3-5.1 10 43 LLE, SPE, derivatization GC-MS 26 
47
 
1OH-Pyr 2.3-5.1 10 43 LLE, SPE, derivatization GC-MS 26 
47
 
1OH-Phen 2.3-5.1 10 43 LLE, SPE, derivatization GC-MS 26 
47
 
2OH-Phen 2.3-5.1 10 43 LLE, SPE, derivatization GC-MS 26 
47
 
3OH-Phen 2.3-5.1 10 43 LLE, SPE, derivatization GC-MS 26 
47
 
4OH-Phen 2.3-5.1 10 43 LLE, SPE, derivatization GC-MS 26 
47
 
9OH-Phen 2.3-5.1 10 43 LLE, SPE, derivatization GC-MS 26 
47
 
1OH-Pyr 0.03 ng 10 NA LLE, SPE HPLC-FL 53 
45
 
2OH-Flu 0.05 10 NA LLE, SPE, derivatization GC-MS 34 
50
 
1OH-Pyr 0.05 10 NA LLE, SPE, derivatization GC-MS 34 
50
 
3OH-B[a]P 0.39 10 NA LLE, SPE, derivatization GC-MS 34 
50
 
3OH-Phen 0.04 10 NA LLE, SPE, derivatization GC-MS 34 
50
 
1OH-Pyr 0.1 5 32 LLE, SPE HPLC-FL 70 
48
 
1OH-Pyr 0.04 10 NA LLE, SPE, derivatization GC-MS 30 
46
 
3OH-B[a]P 0.07 10 NA LLE, SPE, derivatization GC-MS 30 
46
 
2OH-Phen 0.08 10 NA LLE, SPE, derivatization GC-MS 30 
46
 
3OH-Phen 0.04 10 NA LLE, SPE, derivatization GC-MS 30 
46
 
a) Volume of milk b) LLE: liquid-liquid extraction c) Instrumental analysis only; does not include sample preparation procedures. 
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Although chromatographic techniques provide reliable results in the analysis of OH-
PAH, their experimental procedures are time consuming and expensive. Elution times of 30-60 
minutes are typical and standards must be run periodically to verify retention times. If the 
concentrations of target species are found to lie outside the detector’s response range, the sample 
must be diluted and the process repeated. On the other end of the concentration range, many 
samples are “zeroes,” i.e. the concentrations are below detection limits. Additional problems 
arise when laboratory procedures are scaled up to handle thousands of samples under mass 
screening conditions. Under the prospective of a sustainable environment, the large usage of 
organic solvents is one of the main limitations of the current chromatographic methodology.   
Research in our group has focused on the development of a screening methodology for 
OH-PAH.
35, 51, 52
 Screening techniques capable of providing a “yes or no” answer to OH-PAH 
contamination prevent unnecessary scrutiny of un-contaminated samples via conventional 
methods, reduce analysis cost and expedite the turnaround time for decision making purposes. 
The remaining of this chapter is then devoted to cover the basic principles of the techniques we 
chose for the development of screening methodology, namely capillary electrophoresis (CE) and 
synchronous fluorescence spectroscopy (SFS). 
 
1.3 Capillary Electrophoresis (CE) 
CE is an analytical technique used for the separation of a variety of analytes such as small 
molecules, peptides and proteins. Unlike chromatography, in which separation is the result of the 
different affinities of the sample components with the stationary and mobile phases, separation in 
CE is based on the size and on the amount of charge of the analytes. Analyte migration takes 
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place on the inside of a small bore capillary filled with a solution of a buffer electrolyte. When 
an electric field is applied across the capillary, species migrate with a mobility that is directly 
proportional to their charge and inversely proportional to their size. This means that if two ions 
have the same size but one has a greater charge, it will move faster; and in the same way if two 
ions have equal charges but one has a larger size, it will exhibit more friction with respect to the 
solvent and therefore will migrate slower than the smaller ion. 
CE analyses provide high resolution separations since the two main sources of band 
broadening that take place in a separation column, i.e. eddy diffusion and mass transfer are 
eliminated due to the lack of packing in the capillary tube. The only source of band broadening 
in CE is longitudinal diffusion, which can result in a plate number one order of magnitude higher 
than those obtained with chromatographic methods, especially for large molecules with low 
diffusion coefficients such as proteins. Another advantage of CE is the low sample (~10
-9
 L) and 
solvent consumption, making it less expensive to run and maintain than HPLC. It also means that 
it is a more environmentally friendly technique since it minimizes the use of potentially toxic 
organic solvents. 
The simplest form of CE is capillary zone electrophoresis (CZE), in which analytes are 
separated, in a capillary previously filled with a buffer, into different zones. This technique 
works well for cationic and anionic analytes, neutrals will not separate under such conditions. To 
expand the application of CE to neutral and charged molecules, a type of CE called micelar 
electro-kinetic chromatography (MEKC) can be used. In this technique, a surfactant is added to 
the buffer to form micelles, which will serve as a pseudo-stationary phase similar to HPLC. 
Analytes will interact in a variety of ways with the micelle and they will show a certain 
partitioning between the aqueous phase and the micelle, which will contribute to separation. This 
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partitioning can be regulated by changing experimental conditions such as salt content, 
temperature, pH, and addition of ion paring and complexing agents. Another additive that can be 
added to the buffer are cyclodextrins (CD), which are cyclic oligosaccharides possessing a cavity 
that can interact with analytes, improving separations based on partitioning of the analyte 
between the solution and the CD. Given the amount of variables to optimize in MEKC, a simpler 
approach such as CZE is preferred.  
 
1.3.1 Electrophoretic mobility and electro-osmotic flow 
Electrophoresis is the movement of charges under an applied electric field. In CE, the 
movement of charged species will have an electrophoretic component that will exert a force 
towards the appropriate electrode, i.e. a positively charge particle will tend to migrate towards 
the cathode (negative electrode) and a negatively charged particle will be attracted by the anode 
(positive electrode). The electrophoretic mobility (μE) will depend on the size of the solute ion 
and the charge it bears, i.e. the charge/mass ratio: 
    
 
 
 
 
      
     (1.1) 
where q is the solute charge,   is a frictional coefficient given by the Stokes’ law (assuming 
spherical particle), η is the viscosity of the liquid and r is the radius of the particle. The resulting 
electrophoretic velocity (v) will be dependent on μE and the applied electric field (E): 
            (1.2) 
 When a potential is applied across a capillary filled with an electrolyte solution, this 
electrolyte solution will move from one end of the capillary to the other. The explanation of this 
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phenomenon is related to the chemical nature of the inside wall of fused silica capillaries. Silanol 
groups (Si-OH) are an integral part of fused silica capillaries and are exposed to the electrolyte 
solution. At pH values higher than four, these silanol groups will begin to deprotonate and 
become ionized to negatively charged silanolate (Si-O
-
). Positive ions in solutions will become 
attracted to the newly formed negative charges on the capillary wall forming a double layer. The 
first layer or “fixed layer” will be tightly held to the negatively charged silanols and the second 
layer (diffuse layer) will form at a greater distance from the capillary wall and will have freedom 
to move under the influence of an external electric field. When the ions from the diffuse layer 
move so does the water molecules solvating them, therefore the bulk of the electrolyte solution 
experiences a net flow towards the cathodic end of the capillary referred to as the electro-osmotic 
flow (EOF): 
      
  
 
      (1.3) 
where μEOF is the EOF mobility, ε is the dielectric constant of the electrolyte solution and ζ is the 
zeta potential. Since the zeta potential depends on the charge of the capillary wall and on the 
level of ionization of silanol groups, the buffer pH usually plays a very important role in 
determining EOF velocity. 
 
1.3.2 Instrumental set-up 
CE instrument main components are a capillary tube, two buffer reservoirs, two 
electrodes, a high power voltage supply, a sample introduction system (or autosampler) and a 
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detector connected to a data acquisition device. A schematic representation of a typical CE 
system is illustrated in Figure 1.3.  
 
 
Figure 1.3 Schematic of a capillary electrophoresis system 
 
Capillaries are constituted by fused silica and have an outer diameter of ~ 0.4 mm. Since 
this material can be fragile and can break easily upon slight bending, a polyimide coating is used 
to provide the capillary with physical support. A small portion of a few mm of this coating is 
usually burned-off to expose the silica and act as a window to perform detection on the capillary, 
since fused silica is transparent to UV and visible light. The capillary is filled with an electrolyte 
solution and is connected to two buffer reservoirs. A high voltage power supply is also connected 
to the buffer vials by means of two electrodes which help produce en electric field across the 
Capillary 
Detector 
 
 
 
Sample 
Inlet buffer  Outlet 
buffer 
High voltage power 
supply 
- + 
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capillary to generate the electrophoretic phenomena and also the EOF. Sample injection can be 
done in two ways: hydrodynamically or electrokinetically. In hydrodynamic injection the 
capillary is placed in the sample vial and a certain volume of sample is pressure driven into the 
capillary. In electrokinetic injection, upon immersion of the capillary in the sample vial a voltage 
is applied causing two effects: movement of the buffer inside of the capillary, which will push a 
volume of sample via siphoning, and electrophoretic migration of sample ions. These two 
methods of sample injection usually last only a few seconds and result in injections of nano-liter 
volumes of sample solution. The detector is typically placed at the cathodic end of the capillary 
and it can be UV-Vis, fluorescence, electrochemical or refractive index. 
 
1.3.3 Sample Stacking 
Absorption spectroscopy is one of the most popular detection modes in CE but its 
sensitivity is quite modest. Several strategies exist to improve ultraviolet- visible (UV-Vis) 
LODs. These include increasing optical path lengths with the aid of bubble,
53, 54
 Z- or U-shaped 
detection cells,
53, 54
 solid-phase extraction (SPE)
55
 and in-capillary micro-extraction.
67, 68
 Another 
alternative for improving the sensitivity of CE is an on-line pre-concentration technique called 
sample stacking. Sample stacking is based on the different conductivities of the sample solution 
and the CE running buffer solution.
56
 The only requirement for its successful application is to 
operate with a sample solvent of lower conductivity than the running buffer solution. This 
requirement is usually met with either a diluted background electrolyte or a pure solvent such as 
methanol. When an electric potential is applied across the separation capillary, an amplified 
electric field is created in the sample zone. Under the influence of the electric field, sample ions 
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migrate from the high to low drift velocity region. This migration leads to a local accumulation 
or ‘stacking’ of sample ions near the interface between regions of high and low conductivity. 
After crossing this boundary the thin zone of ions moves through the running buffer and 
separates into individual zones under normal electrophoretic conditions. The stacking 
mechanism occurs for both positively and negatively charged species. The positive species stack 
up in front of the sample plug while the negative species stack up in the back of the sample plug. 
The neutral compounds are left in the sample plug and co-elute. In comparison to conventional 
CZE, sample stacking allows the analyst to increase sample loading (up to a certain threshold 
value) at no cost of separation efficiency. The narrow zones of concentrated ions often enhance 
signal intensities and improve the sensitivity of CZE measurements.
57, 58
 
 
1.4 Fluorescence Spectroscopy 
1.4.1 Basic Principles 
Fluorescence spectroscopy is based on the detection of radiation emitted during the 
deactivation of electronically excited molecules.
59-61
 Under normal conditions, the orbital of 
lowest energy of an organic molecule are occupied by pairs of electrons with spin in opposite 
directions.
62
 Since most of the organic molecules have an even number of valence electrons, the 
resulting electron spin is zero. Such a state, with no net spin, is called a singlet state. The singlet 
state of lowest energy is known as the ground state, and it is represented in the Jablonski diagram 
of Figure 1.4 by S0. Through the absorption of electromagnetic radiation (A), a molecule can 
pass from the ground state to an excited state of higher energy. This transition occurs in 
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approximately 10
-15
 s and entails the promotion of an electron from the highest occupied orbital 
to a previously unoccupied one. If the transition occurs with no change in the spin of the 
promoted electron, the excited state will have two unpaired electrons with anti-parallel spins and, 
therefore, net spin equal to zero. An electronic state with these characteristics is known as a 
singlet excited state. In Figure 1.4 the first and second singlet-excited states are represented by 
S1 and S2, respectively. If the transition involves a change in the electronic spin, the excited 
state will be characterized by two unpaired electrons with parallel spins. In this case, the 
resultant spin is one, and the excited state receives the name of triplet state. In Figure 1.4, the 
triplet state of the lowest energy is symbolized by T1 while any other triplet state of higher 
energy is represented by Tn.  
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Figure 1.4 Jablonski diagram. A is the absorption, F is the fluorescence, P is the phosphorescence, VR is the 
vibrational relaxation, IC is internal conversion, and ISC is the intersystem crossing. 
 
When the energy of an absorbed photon is enough to excite a molecule to a state such as S2, it 
usually releases the extra vibrational energy to reach the lowest vibrational level of the state. 
This radiationless deactivation mechanism is known as vibrational relaxation (VR), and it is the 
consequence of the energy transfer from the excited molecule to the surrounding medium in the 
form of thermal energy. Through another radiationless process called internal conversion (IC), 
the molecule passes from the lowest vibrational level of S2, to a vibrational level of S1. This 
process results in the transformation of excitation energy into vibrational-rotational energy
63
 and 
occurs between electronic states of the same multiplicity.
64
 The lowest vibrational level of S1 is 
then reached through VR. If the molecule was initially excited to a higher excited state than S2, 
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the lowest vibrational level of S1 would be reached by a succession of IC and VR processes. 
From the lowest vibrational level of S1, the molecule has two ways of directly returning to the 
ground state: through IC, without the emission of radiation, or by the emission of a photon with 
no change in the electronic spin. The latter process is responsible for the emission of 
fluorescence and occurs in a time period of 10
-10
 to 10
-7
 s. The energy of the emitted photon 
corresponds to the energy gap between the lowest vibrational level of S1 and the ground state. 
When the lowest vibrational level of the S1 state overlaps with S0, the excited state is deactivated 
by nonradiative relaxation, and the emission of fluorescence does not occur. 
When the emitted photon has the same energy as the one initially absorbed, the process is 
termed resonance fluorescence. Most times, however, the energy loss in VR and IC results in the 
emission of fluorescence at longer wavelengths than the excitation wavelength, and resonance 
fluorescence is not observed.  
The remaining possibility to return to S0 from S1 begins with a process called 
intersystem crossing (ISC). ISC is radiationless mechanism involving systems of different 
multiplicity which requires a change in the electronic spin.
62
 Although this kind of transition has 
a much lower probability to occur than spin-allowed transition,
61, 62
 the time scale of ISC is 
similar to the one for fluorescence (10
-10 – 10-7 s); therefore, it competes with fluorescence for 
the deactivation of S1. From S1, the molecule can then pass to the excited triplet state manifold 
(Tn) and reach, by a succession of VR an IC processes, the lowest vibrational level of T1. From 
T1, and through ISC, the molecule can revert back to the excited singlet state manifold. Since the 
triplet states have lower energy than the corresponding singlet states, the transition from T1 to S1 
requires some additional activation energy. This activation energy can be obtained either by a 
thermal process or by the interaction of two molecules in the triplet state to produce one 
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molecule in the excited singlet state.
62, 63
 The emission of radiation from the excited S1 to S0 
receives the name of delayed fluorescence. If reverse ISC does not occur, the molecule has two 
additional possibilities to return from T1 to S0: through ISC followed by VR or through the 
emission of radiation in a process called phosphorescence (P). The emission of phosphorescence 
involves states of different multiplicity and, as a consequence, has a longer lifetime than 
fluorescence (between 10
-3
 and 10 s). Since the energy gap between T1 and S0 is usually smaller 
than the one between S1 and S0, phosphorescence occurs in a region of larger wavelength than 
fluorescence. 
 
1.4.2 Synchronous Fluorescence Spectroscopy  
Conventional fluorescence spectra - in which either the excitation or the emission 
wavelength is set at its maximum position while the other is scanned – present limited 
selectivity. The similarity and/or overlapping of broad fluorescence bands at room temperature 
usually interfere in the characterization of targeted compounds without previous separation. 
Several strategies exist to improve the selectivity of room temperature fluorescence 
measurements. The one employed here is known as synchronous fluorescence spectroscopy 
(SFS). The synchronous excitation approach consists of varying simultaneously both the 
excitation (0) and emission () wavelengths while keeping constant a wavelength interval 
( 0) between them. The judicious choice of the  parameter often leads to spectral 
simplification and resolution of spectral overlapping. An example of spectral simplification due 
to the judicious choise of wavelength interval is shown in Figure 1.5, which compares the 
exitation and flurescence spectra of perylene (top) to synchronous fluorescence spectra recorded 
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at two values (bottom). The synchronous fluorescence spectrum obtained with a  = 10nm 
consists of a single emission peak. The 30nm wavelength difference results in two emission 
peaks. In the analysis of a complex mixture without previous chromatographic separation, the 
direct determination of perylene with a= 10nm should be less prone to spectral overlapping 
than its determination with a = 30nm.  
 
 
Figure 1.5.  Excitation and fluorescence spectra (top) and SFS (bottom) of perylene 
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CHAPTER 2. INSTRUMENTATION 
 
2.1 Absorption Spectroscopy 
Absorbance measurements were carried out with a Varian, Cary 50 model single-beam 
spectrophotometer equipped with a 75-W pulsed xenon lamp, 2 ± 0.1 nm fixed band-pass, ±0.1 
nm wavelength precision, and  a maximum scan rate of 24 000 nm.min
-1
. All measurements were 
made by pouring liquid solutions into 1 cm ×1 cm standard quartz cuvettes. 
 
2.2 Fluorescence Spectroscopy 
Fluorescence spectra were recorded with a spectrofluorimeter (Photon Technology 
International) equipped with a continuous 75 W xenon lamp with broadband illumination (200 – 
1000 nm). The excitation and the emission monochromators had the same reciprocal linear 
dispersion (4 nm mm
-1
) and accuracy (±1 nm with 0.25 nm resolution). Their gratings had 1200 
grooves mm
-1
 and were blazed at 300 nm (excitation) and 400 nm (emission). The detector was a 
photomultiplier tube with spectral response from 185 to 650 nm. Instrument computer control 
was performed with commercial software (Felix32) specifically designed for the system. All 
fluorescence measurements were made at 90° geometry with 1 cm x 1 cm standard quartz 
cuvettes. 
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2.3 pH Meter 
pH measurements were made with an AR-15 pH/mV/°C meter and a glass body standard 
size combination electrode (Fischer Scientific). 
 
2.4 Solution Shaking and Centrifugation 
 Sample shaking was carried out with a Maxi Mix III Rotary Shaker (Thermolyne). 
Centrifugation was performed with a MiniSpin centrifuge (Eppendorf) with 13,400 RPM 
maximum speed and a twelve-position rotor.  
 
2.5 Capillary Electrophoresis 
CZE was carried out with a GPA100 system purchased from Groton Biosystems. Its 
detection unit consisted of a variable, single wavelength absorption spectrometer (Model VUV 
9022-0000; JMST Systems) equipped with a deuterium lamp and a silicon photodiode detector. 
Instrument control was performed with a PC and customized software (WinPrinceCE, PrinCE 
CE systems). Fused-silica capillaries with 50 mm internal diameter and 375 mm outer diameter 
were purchased from Polymicro. Their polyamide coating was removed with a window maker 
(MicroSolv-CE) to provide an UV transparent detection window with an approximate length of 4 
mm. The total length of the capillaries was either 61 or 82 cm, depending on the specific 
application, with a corresponding center of their optical window located at 38 or 58 cm from the 
injection port of the CE instrument, respectively.  
25 
 
CHAPTER 3. SOLID-PHASE EXTRACTION, SAMPLE STACKING AND 
CAPILLARY ELECTROPHORESIS FOR THE ANALYSIS OF 
URINARY POLYCYCLIC AROMATIC HYDROCARBON 
METABOLITES  
Knobel, G., Calimag-Williams, K. and Campiglia, A. D., Analyst, 2012, 137, 5639 – 5647. 
 
3.1 Introduction 
Despite its recognized capability to separate charged species with relevance in 
biochemical,
65
 biological
66
 and biomedical
67
 research, only a few articles exist on the separation 
of PAH metabolites via CE.
29, 68-70
 Baseline resolution of positional isomers has been reported 
via -cyclodextrin-modified micellar electrokinetic chromatography (CD-MEKC)68-70 and 
capillary zone electrophoresis (CZE).
69
 The investigated OH-PAH were 1-hydroxynaphthalene 
(1OH-Naph), 2-hydroxynaphthalene (2OH-Naph) and 1-hydroxybenzo[a]pyrene (1OH-B[a]P),
68
 
3-hydroxybenzo[a]pyrene (3OH-B[a]P),
68, 70
 7-hydroxybenzo[a]pyrene (7OH-B[a]P),
68, 70
 9-
hydroxybenzo[a]pyrene (9OH-B[a]P)
68, 70
 and 12-hydroxybenzo[a]pyrene (12OHB-[a]P).
69, 70 
Metabolite detection was carried out via laser-induced fluorescence (LIF)
29, 68
 or UV-Vis 
absorption spectroscopy.
69, 70
 LIF limits of detection (LODs) were reported at the parts per 
billion (ppb) concentration levels.
29, 68
 UV-Vis LODs were not reported.
69, 70
 
The lack of reported data on UV-Vis LODs is not surprising. As previously mentioned, 
the sensitivity of absorption detection in CE is quite modest. 
53, 54
 Z- or U-shaped detection 
cells,
53, 54
 solid-phase extraction (SPE)
55
 and in-capillary micro-extraction.
71, 72
 Previous work by 
our group reported the first application of in-capillary micro-extraction capillary zone 
electrophoresis (CZE) for the urine analysis of OH-PAH.
73
 Hydrolyzed urine samples were 
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submitted to a manual SPE procedure optimized in our lab.
35
 In-capillary micro-extraction of 
OH-PAH was carried out from methanol SPE extracts with gold nanoparticle deposited 
capillaries made in-house. Gold nanoparticles were coated on the inner walls of fused silica 
capillaries (50 mm internal diameter) following previously published methodology.
74, 75
 Baseline 
resolution of 1-hydroxypyrene (1OH-Pyr), 9-hydroxyphenanthrene (9OH-Phen), 3OH-B[a]P, 4-
hydroxybenzo[a]pyrene (4OH-B[a]P) and 5-hydroxybenzo[a]pyrene (5OH-B[a]P) was achieved 
with a 100 mM 3-cyclohexylamino-1-propanesulfonic acid (CAPS) buffer solution prepared in 
40% methanol–water v/v. Complete separation was accomplished in approximately 40 min of 
migration time with metabolite recoveries varying from 69.8 ± 5.5 (9OH-Phen) to 80.6 ± 5.3% 
(3OH-B[a]P). UV-Vis LODs varied between 8.8 (9OH-Phen) and 14.4 ng.mL
-1
 (4OH-B[a]P).
73
 
In this chapter, we present significant advances in all fronts. Baseline resolution of 2-
hydroxyfluorene (2OH-Flu), 2OH-Naph, 1OH-Pyr, 9OH-Phen, 3OH-B[a]P, 4OH-B[a]P and 
5OH-B[a]P was achieved in approximately 17 min with a 20 mM borate buffer prepared in 50% 
methanol–water v/v. The SPE procedure was accomplished with the aid of a twelve-port vacuum 
manifold. On-line pre-concentration was performed via sample stacking.
56, 76
 To the extent of our 
literature search, this is the first application of sample stacking to the analysis of OH-PAH. 
Metabolite recoveries varied from 93.2 ± 7.7% (5OH-B[a]P) to 108.7 ± 7.8% (2OH-Naph). 
LODs were at the ppb level ranging from 0.99ppb (3OH-B[a]P) to 8.54ppb (2OH-Naph). The 
new method was found to be free of interference from four pharmacological drugs – naproxen, 
ibuprofen, diclofenac and amoxicillin – that might be found in urine samples of unhealthy 
individuals. 
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3.2 Materials and Methods 
3.2.1 Instrumentation 
Instrumentation for pH measurements, absorption and fluorescence spectroscopy, and 
CZE measurements was previously described in chapter 2. Sample injection for CZE analysis 
was made was via hydrodynamic pressure. Prior to CZE data collection, the silica capillary was 
rinsed for 10 minutes with 0.1 M NaOH and 10 minutes with the running buffer. At the end of 
data collection, the capillary was rinsed for 10 minutes with methanol and 10 minutes with 
Nanopure water to remove residual impurities. The optimized procedure for sample stacking 
consisted of the following steps: (1) the separation capillary was pressure-filled with the running 
buffer; (2) the sample was injected during the optimized time (60 s) at 45 mbar pressure; and (3) 
the buffer vial was re-positioned at the inlet of the separation capillary to carry out metabolite 
separation at a voltage of 30 kV. Fused-silica capillaries with 50 mm internal diameter and 375 
mm outer diameter were purchased from Polymicro. Their polyamide coating was removed with 
a window maker (MicroSolv-CE) to provide an UV transparent detection window with an 
approximate length of 4 mm. The total length of the capillaries was 82 cm and the center of the 
optical window was located at 58 cm from the injection port of the CE instrument. 
The optimized procedure for sample stacking consisted of the following steps: (1) the 
separation capillary was pressure-filled with the running buffer; (2) the sample was injected 
during the optimized time (60 s) at 45 mbar pressure; and (3) the buffer vial was re-positioned at 
the inlet of the separation capillary to carry out metabolite separation at a voltage of 30 kV. The 
total length of the capillaries was 82 cm and the center of the optical window was located at 58 
cm from the injection port of the CE instrument. 
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3.2.2 Reagents 
All solvents were Aldrich HPLC grade. All chemicals were analytical-reagent grade and 
utilized without further purification. Unless otherwise noted, Nanopure water was used 
throughout. 2OH-Flu, 2OH-Naph, 1OH-Pyr, 9OH-Phen, creatinine, naproxen, ibuprofen, 
diclofenac and amoxicillin were purchased from Sigma-Aldrich. 3OH-B[a]P, 4OH-B[a]P and 
5OH-B[a]P were from Midwest Research Institute. The synthetic urine solution was 
manufactured by RICCA Chemical Company (Arlington, TX) and purchased from Fischer 
Scientific. Its chemical composition mimicked main components of human urine at the 
concentrations found in healthy urine samples. Borate buffer was acquired from Fisher 
Scientific. All other chemicals were purchased from Fisher Chemical. Sep-Pak Plus cartridges 
were acquired from Waters. 
 
3.2.3 Preparation of stock solutions 
Stock solutions of OH-PAH were prepared by dissolving pure standards in methanol. 
Creatinine, naproxen, ibuprofen, diclofenac and amoxicillin stock solutions were prepared in 
methanol. All stock solutions were kept in the dark at 4 °C. Prior to use, stock solutions of OH-
PAH were monitored via fluorescence spectroscopy for possible photo-degradation of 
metabolites. Spectral profiles and fluorescence intensities of stock solutions remained the same 
for a period of six months. Working solutions were prepared daily by serial dilution with 
methanol. 
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3.2.4 Sample preparation 
Urine donations from an anonymous volunteer group were pooled, frozen and stored at -
20 °C until further analysis. Urine samples were spiked with micro-liters of stock solutions of 
appropriate concentrations and equilibrated for 30 min to allow for the interaction of metabolites 
and naproxen with urine components such as urea and various salts. Then 2 mL of 0.1 M HCl 
was added to the sample and the mixture was buffered with 10 mL of a 0.05 M potassium 
phthalate sodium hydroxide buffer (pH 5.0). The buffered sample was stirred for 30 minutes to 
allow for urine hydrolysis. 
 
3.2.5 Solid-phase extraction of urine samples 
SPE was carried out with a Visiprep 12 port vacuum manifold (Supelco). Urine samples 
were processed through a Sep-Pak Plus SPE cartridge pre-conditioned with 10 mL of methanol 
and 10 mL of buffered water (pH = 5). The cartridges were then washed with 10 mL of buffered 
water (pH = 5) and air dried for 10 seconds at 15 mm Hg. OH-PAH were eluted with 2 aliquots 
of 1.5 mL of pure methanol. 
 
3.3 Results and Discussion 
3.3.1 Separation of OH-PAH 
Table 3.1 summarizes the migration times, peak resolutions and peak efficiencies of the 
studied metabolites. Baseline resolution of the seven studied metabolites in the shortest possible 
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time was achieved upon optimization of buffer concentration (20 mM), methanol percentage 
(50% v/v), pH (9.7) and temperature (21 °C). Buffer selection was based on the reported range of 
pKa values for the studied metabolites (8.6 ≤ pKa ≤ 10.8).77-81 Borate, whose working pH ranges 
from 8.2 and 10.2, promotes the partial dissociation of metabolites in the separation capillary and 
forces some degree of negative charge on each OH-PAH. Because our detector was placed on the 
negative end (cathode) of the separation capillary, the detection of OH-PAH results from the 
predominance of the electro-osmotic flow EOF) over the electrophoretic mobility OH-PAH). 
The separation of 4OH-B[a]P from 5OH-B[a]P and 3OH-B[a]P from 1OH-Pyr required the use 
of methanol (see Figure 3.1), i.e. an organic modifier capable of reducing EOF. Methanol 
percentages higher than 50% v/v caused peak distortions that compromised separation efficiency. 
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Table 3.1 Migration time, peak resolution and peak efficiency of OH-PAH 
OH-PAH Migration time (min)
a
 Rs
 b
 Efficiency
 c
 
2OH-Flu 12.67 ± 0.02 - 3.42 x 10
5
 
2OH-Naph 13.16 ± 0.02 5.10 2.66 x 10
5
 
9OH-Phen 13.66 ± 0.03 4.58 2.17 x 10
5
 
5OH-B[a]P 14.38 ± 0.03 6.37 2.71 x 10
5
 
4OH-B[a]P 14.59 ± 0.03 1.80 2.48 x 10
5
 
1OH-Pyr 16.32 ± 0.04 13.66 2.30 x 10
5
 
3OH-B[a]P 16.62 ± 0.04 2.39 3.04 x 10
5
 
a
 Values represent the average of 3 independent electrophoretic runs 
b
 Resolution between peaks calculated from 2(t2-t1)/w2-w1. t1 and t2 are migration time of 
peaks 1 and 2, respectively. w1 and w2 are the widths at the base of each peak . 
c
 Calculated from 5.54(tm/w0.5)
2
. tm: migration time. w0.5: width at half height of the peak.  
 
 
The separation occurs due to the apparent electrophoretic mobility app) of each 
metabolite. Because OH-PAH correlates with app according to the equation: 
app = EOF - OH-PAH     (3.1) 
our experiments indicate the following trend for the electrophoretic mobility: 2OH-Flu  2OH-Naph 
 9OH-Phen  5OH-B[a]P  4OH-B[a]P  1OH-Pyr  3OH-B[a]P.
82
 OH-PAH is directly proportional to the 
metabolite’s charge and inversely proportional to its solvation radius. The magnitude of the 
negative charge depends on the fraction of the dissociated metabolite () at the experimental pH 
of the separation buffer, i.e.  = 10-pKa/10-pKa + 10-pH.83 The migration times of the three 
benzo[a]pyrene metabolites – which probably have similar solvation radii – are in good 
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agreement with the relative values of the reported pKa
81
; i.e. pKa3OH-B[a]P  pKa4OH-B[a]P   
pKa5OH-B[a]P. Assuming no significant changes of the acid dissociation constants with the 
composition of the separation medium, prediction of the a values at the pH of the separation (9.7) 
leads to the following trend: 3OH-B[a]P > 4OH-B[a]P > 5OH-B[a]P. This trend is in good agreement 
with the relative values of the electrophoretic mobilities of the three benzo[a]pyrene metabolites. 
 
 
Figure 3.1 Electropherograms of a synthetic mixture of the studied metabolites separated with 20mM borate 
buffer prepared in methanol-water mixtures. 
Peak identification: (1) EOF marker (methanol); (2) 2OH-Flu; (3) 2OH-Naph; (4) 9OH-Phen; (5) 5OH-B[a]P; 
(6) 4OH-B[a]P; (7) 1OH-Pyr; (8) 3OH-B[a]P. Buffer pH = 9.7; voltage 30kV; temperature 21°C. 
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3.3.2 SPE optimization 
Numerous SPE methods exist for the analysis of OH-PAH in urine samples. Typically, 
metabolites are extracted via reverse-phase interactions with commercial cartridges containing 
C-18 alkyl chains chemically bound to silica particles. OH-PAH elution is carried out 
predominantly with methanol. Using the same type of solid sorbent and eluting solvent, our 
optimization studies focused on obtaining both high pre-concentration factors (CFs) and overall 
metabolite recoveries. CFs in SPE correlate with the ratio between volume of the sample (VS) 
and volume of the eluting solvent (VE); i.e. CF = VS / VE. For any volume of the eluting solvent, 
the best CF values are obtained when the sample volume matches the breakthrough volume of 
the solid sorbent. Sample volumes larger than the breakthrough volume are prone to analyte 
losses. Within the context of urine analysis, where the volume of the sample is sometimes 
limited, a compromise was made (VS = 60 mL) based on the literature values (10–250 mL) 
considered to be appropriate for urine analysis.
38, 84, 85
 VE was reduced to its minimum possible 
value (3 mL) at no cost of metabolite recoveries. 
The overall recoveries were optimized by monitoring the concentrations of OH-PAH via 
room-temperature fluorescence (RTF) spectroscopy, i.e. a technique with a well-known ability to 
monitor trace concentration levels of metabolites in liquid solutions.
86
 Excitation and 
fluorescence spectra of the studied metabolites are provided in Appendix A of this dissertation. 
Because the adsorption of OH-PAH onto the solid sorbent occurs from an aqueous-based matrix 
(urine), the initial survey of excitation and emission spectra was carried out in methanol–water 
(0.05% v/v) and methanol. All spectra were recorded using the same excitation and emission 
band-pass (2 nm). This band-pass provided appropriate signal-to-background ratios (S/B = 3) for 
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analytical use at the parts-per-billion (ng.mL
-1
) concentration level. No attempts were made to 
adjust slit widths to optimize spectral resolution, nor were the spectra corrected for instrumental 
response. The spectral features of the studied metabolites were virtually the same in the two 
types of solvents. Apparently, the solvation effect of methanol in the aqueous solution provides a 
similar micro-environment to the one in pure methanol. 
Table 3.2 summarizes the RTF analytical figures of merit (AFOM) of the studied 
metabolites in the two types of solvents. Fluorescence measurements were made at the maximum 
excitation wavelength (ex) and maximum emission wavelength (em) of each metabolite. The 
correlation coefficients of the calibration curves were close to unity, indicating a linear 
relationship between OH-PAH concentration and fluorescence intensity. The lowest 
concentrations of the linear dynamic ranges (LDR) correspond to the limit of quantitation (LOQ) 
of the calibration method. The LOQ was calculated according to the formula LOQ = 10SB/m; 
where SB is the standard deviation of the average blank signal from a minimum of sixteen 
measurements (N = 16) at the ex and em of each metabolite and m is the slope of the calibration 
curve. The LOD was calculated according to the formula LOD = 3SB/m.
87
 No efforts were made 
to experimentally obtain the upper concentration limits of the calibration curves. The highest 
concentrations in Table 3.2 already surpass the concentration thresholds of OH-PAH often found 
in urine samples.
34, 38, 41
 It is important to note, however, that the experimental concentrations did 
not surpass the breakthrough volume of the SPE device for a sample volume of 60 mL.
88
 At 
LOQ concentrations, the relative standard deviations (RSD) of the average RTF signals (N = 6) 
varied between 5 and 7%. These RSD values demonstrate the ability to precisely monitor OH-
PAH at the parts-per-billion concentration level. 
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Table 3.2 RTF analytical figures of merit of OH-PAH in methanol/water and methanol 
OH-PAH ex/em
a
 
 Methanol/water (0.05% v/v)  Methanol 
 LDR
b
 R
2c
 LOD
d
 LOQ
e
  LDR
b
 R
2c
 LOD
d
 LOQ
e
 
2OH-Naph 331/357  12.2 - 100 0.9999 3.682 12.16  1.45 - 100 0.9990 0.431 1.450 
2OH-Flu 278/328  1.58 - 50 0.9999 0.478 1.577  1.58 - 50 0.9997 0.474 1.578 
9OH-Phen 305/367  2.38 - 100 0.9989 0.720 2.376  1.01 - 100 0.9998 0.304 1.012 
1OH-Pyr 348/387  0.23 - 50 0.9997 0.070 0.231  0.23 - 50 0.9983 0.068 0.226 
3OH-B[a]P 382/432  0.31 - 50 0.9933 0.094 0.312  0.18 - 50 0.9998 0.054 0.180 
4OH-B[a]P 372/421  4.85 - 50 0.9911 1.450 4.850  0.30 - 50 0.9977 0.089 0.300 
5OH-B[a]P 301/430  5.49 - 50 0.9953 1.650 5.490  0.23 - 50 0.9932 0.069 0.230 
a
 Maximum excitation and emission wavelength in nm. 
b
 Linear dynamic range in ng/mL. 
c
 Correlation coefficient of calibration 
curve. 
d
 Limit of detection (ng/mL) is calculated from 3 x standard deviation (Sb) of 16 blank measurements divided by slope 
(m) of the calibration curve. 
e
 Limit of quantification (ng/mL) is calculated from 10 Sb /m. 
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During the course of our experiments, we noted a strong dependence between the elution 
of OH-PAH and the duration of the air drying step, which consisted of aspirating air through the 
cartridge with the aid of the vacuum manifold. 5–10 minutes of air drying caused the recoveries 
of some OH-PAH to fall below 30%. 10 s of drying time at 15 mm Hg removed most of the 
water from the cartridge with no loss in metabolite recoveries. The main reason for removing the 
excess water prior to metabolite elution was to minimize its presence in the methanol solutions 
used for CE injection and sample stacking. 
The percentage of extraction (%EX) was calculated with the formula: 
%EX = (IB – IA) x 100 (3.2) 
where IB and IA refer to the fluorescence intensity of the solution before and after extraction, 
respectively. The eluting efficiency (%EL) of methanol was obtained from the following 
equation: 
%EL = (ME / MR) x 100 (3.3) 
where ME and MR correspond to the eluted and retained mass of OH-PAH, respectively. The 
mass of eluted metabolite was calculated from the product ME = VE x CE, where VE is the 
volume of eluted methanol and CE is the metabolite concentration in the eluted methanol. CE 
values were obtained from the calibration curves in Table 3.2. The mass of retained metabolite 
was calculated from the product MR = CST x VST x %R, where VST is the volume of the standard 
solution processed through the cartridge, CST is the metabolite concentration in the standard 
solution, and %R is the percentage of retention which is equivalent to %EX from equation (3.2). 
Table 3.3 summarizes the figures of merit for the optimized SPE procedure in aqueous 
and urine samples. Metabolites were spiked into the urine matrix 24 h prior to analysis. All 
metabolite concentrations were at the parts-per-billion level. Spiked samples were submitted to 
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acidic hydrolysis and then extracted via SPE. The overall recoveries (%OR) were calculated 
using the following equation: 
%OR = %EX · %EL     (3.4) 
The standard deviations of the overall recoveries (SOR) were based on three repetitions of 
the entire SPE procedure and were calculated as SOR / %OR = [(SEX / %EX)
2
 + (SEL / %EL)
2
]
1/2
, 
where SEX and SEL are the standard deviations of %EX and %EL, respectively.48 Within a 
confidence interval of 95% (N = 3), the overall recoveries were statistically the same in water 
and urine samples. This agreement demonstrates that the matrix composition of the urine sample 
does not interfere with the recoveries of OH-PAH. 
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Table 3.3 Figures of merit for the optimized SPE procedure in aqueous and urine samples 
OH-PAH
a
 
% Extraction (EE) 
EE ± Sext
b
 
 
% Elution (EL) 
EL ± Selu
c
 
 
% Overall Efficiency (OE) 
OE ± SOE
d
 
 
texp
e
 H2O/CH3OH Urine  H2O/CH3OH Urine  H2O/CH3OH Urine  
2OH-Naph 95.7 ± 0.4 96.7 ± 2.1  96.9 ± 0.8 99.9 ± 2.6  92.7 ± 0.9 96.6 ± 3.4  1.023 
2OH-Flu 99.9 ± 0.1 99.8 ± 0.3  99.3 ± 1.8 95.7 ± 2.9  99.2 ± 1.8 95.5 ± 3.0  1.838 
9OH-Phen 98.8 ± 0.1 99.3 ± 0.3  91.4 ± 1.8 88.6 ± 1.3  90.3 ± 2.0 87.9 ± 1.5  1.724 
1OH-Pyr 99.3 ± 0.2 99.6 ± 0.4  89.1 ± 1.3 88.5 ± 1.0  88.5 ± 1.5 88.1 ± 1.1  0.331 
3OH-B[a]P 99.0 ± 0.3 99.6 ± 0.1  99.2 ± 1.4 99.8 ± 1.0  98.2 ± 1.5 99.4 ± 1.1  1.179 
4OH-B[a]P 96.7 ± 0.2 94.2 ± 1.9  86.2 ± 1.4 89.0 ± 1.9  83.3 ± 1.1 83.8 ± 3.6  0.467 
5OH-B[a]P 99.1 ± 0.4 99.4 ± 0.2  93.7 ± 1.3 91.3 ± 2.1  92.9 ± 1.3 90.7 ± 2.1  1.521 
a
 The final concentrations of spiked samples are 50 ng/mL for , 2OH-Naph, 2OH-Flu, and 9OH-Phen and 20 ng/mL for 1OH-Pyr, 3OH-
B[a]P, 4OH-B[a]P and 5OH-B[a]P. 
b
 % Standard deviation of % retention efficiency.
c
 % Standard deviation of % elution efficiency. 
d
 % 
Standard deviation of % overall efficiency. 
e
 texp – t value calculated for experimental measurements according to 
87
. ttab = 2.78 (α = 0.05; 
N1 = N2 = 3). 
 
 
39 
 
3.3.3 Optimization of sample stacking 
Sample stacking is based on the different conductivities of the sample solution and the 
CE running buffer solution. The only requirement for its successful application is to operate with 
a sample solvent of lower conductivity than the running buffer solution. This requirement is 
usually met with the use of a diluted background electrolyte
56
 or a pure solvent such as 
methanol.
57
 In comparison to conventional CZE, sample stacking allows the analyst to increase 
sample loading at no cost of separation efficiency.
58
 The general optimization strategy is to 
monitor the amount of sample loading as a function of both peak height and peak broadening. 
Figure 3.2 (A) correlates the peak heights of the studied metabolites with injection times made at 
45 mbar of hydrostatic pressure. Intensity values are averages of three measurements. In 
comparison to 60 s, 90 s of injection time reduced the peak heights of 9OH-Phen and 3OH-
B[a]P. The peak heights of the remaining metabolites increased with injection time. Figure 3.2 
(B) compares the electropherograms recorded at 60 and 90 s of injection times. Clearly, 90 s of 
injection time caused deterioration in peak shape and compromised metabolite separation. The 
stacking effect under optimized conditions is shown in Figure 3.3, which compares the 
electropherograms of two synthetic standard mixtures prepared in either 100% methanol or the 
running buffer (20 mM borate; 50% methanol; pH = 9.7) of the CZE separation. The separation 
conditions were the same in both cases. Based on these observations, we chose 60 s as the 
optimal injection time for all further studies. 
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Figure 3.2 (A) Peak heights of OH-PAH as a function of injection time; (B) electropherograms of a synthetic 
mixture with the studied metabolites using injection times of 90 seconds (top) and 60 seconds (bottom). 
Metabolites were separated using 20mM borate buffer prepared in methanol-water 50% v/v. Peak 
identification as in Figure 3.1 Buffer pH = 9.7; voltage = 30 kV; temperature = 21 °C. 
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Figure 3.3 Electropherograms of two synthetic mixtures of the studied metabolites prepared in pure methanol 
(top) and in the separation buffer (bottom). 
OH-PAH concentrations and hydrodynamic injection times (60 seconds) were the same in both cases. Buffer: 
20mM borate, 50% v/v methanol; pH = 9.7; voltage = 30 kV; temperature = 21 °C. Peak identification: (1) 
EOF marker (methanol); (2) 2OH-Flu; (3) 2OH-Naph; (4) 9OH-Phen; (5) 5OH-B[a]P; (6) 4OH-B[a]P; (7) 
1OH-Pyr; (8) 3OH-B[a]P.  
 
3.3.4 Analytical figures of merit 
Table 3.4 summarizes the AFOM obtained via sample stacking and CZE analysis. 
Calibration curves were built with standard mixtures containing known concentrations of the 
seven metabolites in methanol. All LDR were based on the average peak heights of at least five 
OH-PAH concentrations. The average peak heights plotted in the calibration graphs correspond 
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to a minimum of three measurements made from triplicate aliquots submitted to three complete 
experimental trials. The correlation coefficients (data not shown), the slopes (data not shown) 
and the intercepts (data not shown) of the linear fittings were calculated with the least squares 
method.
89
 The R
2
 values close to unity confirm the existence of linear relationships in all cases. 
The lowest concentrations of the LDR correspond to the LOQ, which were calculated according 
to the formula LOD = 10SB/m; where SB is the standard deviation of the average blank signal 
estimated from one-fifth of the peak-to-peak noise (Np–p/5) and m is the slope of the calibration 
curve.
90
 The Np–p was measured at the base peak of each OH-PAH over a sufficiently wide 
region of the electropherogram. No efforts were made to reach the experimental values of the 
upper concentration limits of the calibration curves. The RSD values at medium linear 
concentrations show excellent reproducibility of measurements. On the other end, the LOD 
values stress the need for SPE prior to sample stacking–CZE analysis. LOD values in Table 3.4 
are at the higher end of typical OH-PAH concentration ranges in urine samples.
22, 34, 38, 40-42, 91, 92
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Table 3.4 AFOM of CZE analysis of OH-PAH 
OH-PAH LDR (ppm)
a
 R
2
 LOQ (ppb)
b
 LOD (ppb)
b
 RSD % 
2OH-Flu 0.091 – 5 0.999 91 28 2.34 
2OH-Naph 0.582 – 5 0.999 582 176 1.04 
9OH-Phen 0.103 – 5 0.996 103 31 1.36 
5OH-B[a]P 0.056 – 5 0.999 56 17 5.75 
4OH-B[a]P 0.081 – 5 0.999 81 24 6.16 
3OH-B[a]P 0.066 – 5 0.998 66 20 2.16 
1OH-Pyr 0.165 - 5 0.988 165 50 6.56 
a
 Linear dynamic range. 
b
 Limit of detection and limit of quantitation calculated as 3 SB/m 
and 10 SB/m, respectively; where SB is the standard deviation of the average blank signal 
and m is the slope of the calibration curve. 
 
 
3.3.5 Analysis of synthetic urine samples 
Table 3.5 summarizes the AFOM obtained via SPE, sample stacking and CZE analysis of 
synthetic urine samples. Calibration curves were built with standard mixtures containing known 
concentrations of the seven metabolites in urine. Synthetic urine spiking and hydrolysis, SPE and 
sample stacking were carried out as previously described in this chapter. The R
2
, LOD and LDR 
were calculated as those reported in Table 3.4. LDR were based on the average peak heights of at 
least five OH-PAH concentrations. The average peak heights plotted in the calibration graphs 
correspond to a minimum of three measurements made from triplicate aliquots submitted to three 
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complete experimental trials. No efforts were made to reach the experimental values of the upper 
concentration limits of the calibration curves. Metabolite recoveries were calculated from three 
urine aliquots (N = 3) submitted to the entire experimental procedure. Within a confidence 
interval of 95% (N = 3), all the recoveries were equivalent to 100%.
87
 Comparison of LODs in 
Table 3.4 and Table 3.5 shows the advantage of using SPE prior to sample stacking. LOD 
improvements varied from ~ 14x (3OH-B[a]P) to ~23x (1OH-Pyr). Their values in Table 3.5 
demonstrate the ability of the new method to determine OH-PAH at the low-ppb concentration 
level. 
 
 
Table 3.5 SPE-CZE analytical figures of merit of OH-PAH in synthetic urine samples  
OH-PAH LDR (ppb)
a
 R
2
 LOQ (ppb)
b
 LOD (ppb)
b
 Recovery (%)
c
 
2OH-Flu 3.9 – 20 0.983 3.9 1.2 108.4 ± 9.1 
2OH-Naph 30 – 100 0.993 30.2 9.2 92.9 ± 6.2 
9OH-Phen 4.5 – 20 0.992 4.5 1.4 108.2 ± 7.5 
5OH-B[a]P 2.7 – 20 0.983 2.7 0.8 97.9 ± 8.0 
4OH-B[a]P 4.2 – 20 0.992 4.2 1.3 93.6 ± 5.2 
3OH-B[a]P 4.8 – 20 0.990 4.8 1.4 96.8 ± 5.2 
1OH-Pyr 7.2 – 50 0.992 7.2 2.2 105.5 ± 7.2 
a
 Linear dynamic range. 
b
 Limit of detection and limit of quantitation calculated as 3 SB/m and 
10 SB/m, respectively; where SB is the standard deviation of the average blank signal and m is 
the slope of the calibration curve. 
c
 Recoveries calculated from three urine aliquots (N=3) 
submitted to the entire experimental procedure. 
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Figure 3.4 displays an electropherogram of a synthetic urine sample previously spiked 
with the seven metabolites and five potential concomitants. Creatinine is a metabolite that 
appears in urine at a constant rate and is often monitored to check possible sample manipulation 
in standard drug tests.
93
 Naproxen, ibuprofen and diclofenac are non-steroidal anti-inflammatory 
drugs
94, 95
 and amoxicillin is an antibiotic.
96
 Because these pharmacological drugs are frequently 
used in our society, it is possible to find them in urine samples of unhealthy individuals. The 
final concentrations of the five concomitants in the spiked samples were within the range of 
concentrations usually found in human urine samples.
93-96
 Although the SPE procedure does not 
remove any of these concomitants from the analytical sample, their presence in the 
electropherogram does not overlap with the migration of the studied metabolites. 
  
46 
 
 
Figure 3.4 Electropherogram of a synthetic mixture with the studied metabolites and four possible 
interferents. 
Separation was achieved using 20 mM borate buffer prepared in methanol-water 50% v/v. Buffer pH = 9.7; 
voltage = 30 kV; temperature = 21 °C. Peak identification: (1) EOF marker (methanol) and Creatinine; (2) 
2OH-Flu; (3) 2OH-Naph; (4) 9OH-Phen; (5) 5OH-B[a]P; (6) 4OH-B[a]P; (7) 1OH-Pyr; (8) 3OH-B[a]P; (I) 
Ibuprofen; (II) Diclofenac; (III) Amoxicillin; (IV) Naproxen.  
 
3.3.6 Analysis of urine samples 
AFOM obtained via SPE, sample stacking and CZE analysis of urine samples are 
summarized in Table 3.6. Calibration curves were built by spiking urine samples with standard 
mixtures of 7 OH-PAH. Urine spiking and hydrolysis, SPE and sample stacking were carried out 
as previously described. The R2, LOD and LDR were calculated as those reported in the 
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previous section. The average peak heights plotted in the calibration graphs correspond to a 
minimum of three measurements made from triplicate aliquots submitted to three complete 
experimental trials. No efforts were made to reach the experimental values of the upper 
concentration limits of the calibration curves. Metabolite recoveries were calculated from three 
urine aliquots (N = 3) submitted to the entire experimental procedure. Within a confidence 
interval of 95% (N = 3), recoveries were statistically equivalent to those obtained with synthetic 
urine.
87
 
 
Table 3.6 SPE-CZE analytical figures of merit of OH-PAH in urine samples 
OH-PAH LDR (ppb)
a
 R
2
 LOQ  (ppb)
b
 LOD  (ppb)
b
 Recovery  (%)
c
 
2OH-Flu 4.3 – 20 0.987 4.3 1.3 103.8 ± 8.4 
2OH-Naph 28 – 100 0.990 28 8.5 108.7 ± 7.8 
9OH-Phen 6.2 – 20 0.995 6.2 1.8 104.3 ± 6.1 
5OH-B[a]P 3.8 – 20 0.985 3.8 1.1 93.2 ± 7.7 
4OH-B[a]P 5.7 – 20 0.990 5.7 1.7 94.5 ± 6.4 
3OH-B[a]P 3.3 – 20 0.987 3.3 1.0 106.3 ± 9.0 
1OH-Pyr 6.8 – 50 0.993 6.8 2.0 93.8 ± 8.1 
a
 Linear dynamic range. 
b
 Limit of detection and limit of quantitation calculated as 3 SB/m and 
10 SB/m, respectively; where SB is the standard deviation of the average blank signal and m is 
the slope of the calibration curve. 
c
 Recoveries calculated from three urine aliquots (N=3) 
submitted to the entire experimental procedure. 
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Figure 3.5 shows an electropherogram of the analysis of urine previously spiked with 
seven OH-PAH and four pharmacological drugs. Although some of the urine concomitants are 
removed in the washing steps of the SPE process, the ones remaining appear to have larger 
migration times than the PAH metabolites, with the exception of neutral molecules which co-
migrate with the EOF. HPLC experiments in our lab are challenged with the separation of 4OH-
B[a]P and 5OH-B[a]P under a single set of chromatographic conditions.
73
 In addition to similar 
chromatographic behaviors, the strong overlapping of excitation and fluorescence spectra – see 
Figure 3.6 – makes their selective determination in co-eluted HPLC fractions impossible. The 
same is true for Solid-Phase Extraction and Room- Temperature Fluorescence spectroscopy 
(SPE-RTF),
51
 an analytical approach currently investigated in our lab for the direct determination 
of OH-PAH without previous chromatographic separation. The unique electrophoretic pattern of 
4OH-B[a]P and 5OH-B[a]P demonstrates the potential of CZE for the determination of 
positional isomers in urine samples. 
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Figure 3.5 Electropherogram of a human urine sample spiked with the studied metabolites and four possible 
interferents 
Separation was achieved using 20 mM borate buffer prepared in methanol-water 50% v/v. Buffer pH = 9.7; 
voltage = 30 kV; temperature = 21 °C. Peak identification: (1) EOF; (2) 2OH-Flu; (3) 2OH-Naph; (4) 9OH-
Phen; (5) 5OH-B[a]P; (6) 4OH-B[a]P; (7) 1OH-Pyr; (8) 3OH-B[a]P; (I) Ibuprofen; (II) Diclofenac; (III) 
Amoxicillin; (IV) Naproxen.  
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Figure 3.6 Room temperature excitation and fluorescence spectra of 50 μg L-1 4OH-B[a]P (A) and 100 μg L-1 
5OH-B[a]P (B) in methanol. 
Excitation and emission band pass = 2 nm/2 nm. Excitation and emission spectra were recorded at the 
maximum excitation (λexc) and fluorescence (λem) wavelengths = λexc/λem = 376 nm/422 nm (4OH-B[a]P) 
and λexc/λem = 388 nm/445 nm (5OH-B[a]P). 
 
3.4 Conclusion 
We have developed a new method for the analysis of 2OH-Flu, 2OH-Naph, 1OH-Pyr, 
9OH-Phen, 3OH-B[a]P, 4OH-B[a]P and 5OH-B[a]P in urine samples. Baseline resolution of the 
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seven metabolites was achieved in less than 17 minutes of electrophoretic separation. The lack of 
competitive LOD – a main limitation of CZE and UV-Vis absorption detection with commercial 
instrumentation – was overcome with the combination of SPE and sample stacking. Their 
hyphenation was facilitated with the use of a single organic solvent (methanol) for metabolite 
elution and electrophoretic stacking. The obtained LODs were up to two orders of magnitude 
better than reported CZE-LIF LODs,
29, 68
 one order of magnitude better than in-capillary micro-
extraction CZE LODs, and within the LOD range of chromatographic LOD.
22, 40, 41, 91
All CZE 
recoveries were statistically equivalent to 100% (P = 95%; N = 3). To the extent of our literature 
search, our values compare well to the most frequently reported recoveries via GC-MS (≤80%)41, 
42
 and HPLC (≤75%).38, 40, 91, 92 
In comparison to GC-MS, CZE presents the additional advantage of not requiring 
chemical derivatization prior to metabolite separation. The unique electrophoretic pattern of 
3OH-B[a]P, 4OH-B[a]P and 5OH-B[a]P demonstrates the potential of CZE for the unambiguous 
determination of positional isomers with similar chromatographic behaviors and virtually similar 
fragmentation patterns. Our approach might prove useful for the analysis of rather large and 
structurally similar polar metabolites with difficult chromatographic behavior and lengthy GC-
MS derivatization procedures. 
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CHAPTER 4. ANALYSIS OF POLYCYCLIC AROMATIC 
HYDROCARBON METABOLITES IN COW’S MILK BY LIQUID-
LIQUID EXTRACTION AND SYNCHRONOUS ROOM-
TEMPERATURE FLUORESCENCE SPECTROSCOPY 
Knobel, G., Calimag-Williams, K. and Campiglia, A. D., Analytical Methods, 2013, 5, 1577-
1582. 
 
4.1 Introduction 
As shown in Table 1.2, only a few articles exist on the analysis of PAH metabolites in 
cow milks, with emphasis on monohydroxylated PAH (OH-PAH).
45-50
 Most articles have 
focused on the analysis of 1-hydroxypyrene (1OH-Pyr), a metabolite proven to provide a direct 
correlation between its concentration in milk samples and the ruminant ingestion of pyrene.
48, 50
 
Previous work in our group has demonstrated the advantages of combining SPE to room-
temperature fluorescence (RTF) spectroscopy for the analysis of OH-PAH in urine samples.
35, 51, 
52 
Quantitative determination of OH-PAH was carried out either in the eluent extract
35, 51 
or on 
the surface of the extraction membrane.
52 
The strong fluorescence resulting from the rigid and 
delocalized  - electron system of OH-PAH provided competitive LODs with minimum sample 
pre-concentration. Spectral overlapping and matrix interference were eliminated with the aid of 
excitation-emission matrices and chemometrics.
35, 51
 
In this chapter, we present the first application of synchronous RTF spectroscopy to the 
analysis of OH-PAH in liquid-liquid extracts of milk samples. Although synchronous RTF 
spectroscopy has been reported for the analysis of OH-PAH in urine
97-100
 and fish samples,
101-104 
the extent of our literature search revealed no applications toward the analysis of metabolites in 
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milk samples. Herein, we combine synchronous RTF spectroscopy to a new LLE procedure 
consisting of three simple experimental steps, namely sample hydrolysis, mixing of methanol 
with the hydrolyzed sample and centrifugation of the supernatant. 2-hydroxyfluorene (2OH-Flu), 
6-hydroxychrysene (6OH-Chry), 1-hydroxypyrene (1OH-Pyr) and 3-hydroxybenzo[a]pyrene 
(3OH-B[a]P) are directly determined in the supernatant with no need of chromatographic 
separation. The non-destructive nature of LLE-synchronous RTF spectroscopy provides ample 
opportunity for OH-PAH confirmation via chromatographic techniques.  
 
4.2 Materials and Methods 
4.2.1 Chemicals 
All solvents were HPLC grade. All chemicals were analytical-reagent grade and utilized 
without further purification. Unless otherwise noted, Nanopure water was used throughout. 2OH-
Flu, 1OH-Pyr and 6-OHChry were purchased from Sigma-Aldrich. 3OH-B[a]P was from 
Midwest Research Institute. All other chemicals were purchased from Fisher Scientific. Stock 
solutions of OH-PAH were prepared by dissolving pure standards in methanol and were stored in 
the dark at 4 
°
C. Possible photo-degradation of metabolites was monitored weekly via 
fluorescence spectroscopy. Working solutions were prepared daily by serial dilution with 
methanol. 
Note: Use extreme caution when handling OH-PAH known to be extremely toxic. 
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4.2.2 Liquid-liquid extraction 
400μL of commercially available bovine whole milk samples were spiked with micro-
liters of OH-PAH stock solutions of appropriate concentrations. The spiked sample was allowed 
to equilibrate at room temperature and in the dark for 24 hours. Enzymatic hydrolysis was 
carried out following previously established protocol.
50
 After adjusting the pH to 5 with HCl, 1 
μL β-glucuronidase type H-2 from Helix pomatia (MP Biomedicals) with a volume activity of 65 
unit/μl was added to the spiked sample. The mixture was incubated at 37 °C overnight to convert 
glucuronide and sulfate conjugates into free OH-PAH. Following hydrolysis, 1400 μL of 
methanol were added to the sample and the mixture was shaken for 30 minutes at 1,400 RPM. 
Sample centrifugation was carried out in a 2 mL polypropylene tube for 1 min at 13,400 RPM. 
The supernatant was then removed and analyzed with a spectrofluorimeter. 
 
4.2.3 Instrumentation and measurements 
Instrumentation for pH measurements, sample shaking and centrifugation, absorption and 
fluorescence spectroscopy was previously described in chapter 2. 
 Unless otherwise noted, synchronous fluorescence spectra were recorded using a wavelength 
off-set equal to 5 nm and an excitation/emission band-pass of 1 nm. 
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4.3 Results and Discussion 
The four metabolites we chose for this study - 2OH-Flu, 6OH-Chry, 1OH-Pyr and 3OH-
B[a]P - are part of the “EPA-PAH group”, which provide us with ample opportunity to compare 
our analytical figures of merit (AFOM) with previously reported data.
45-50
 
 
4.3.1 Optimization of the LLE procedure  
Literature procedures for the analysis of OH-PAH in milk samples report their extraction 
with a mixture of ethyl acetate/cyclohexane (50/50; v/v), supernatant evaporation, SPE, 
evaporation of the eluent and LLE with cyclohexane and methanol–water (80/20; v/v).45-50 The 
LLE procedure presented here consists of sample mixing and centrifugation with methanol. The 
duration of the mixing and centrifugation steps were optimized fort short analysis time with no 
compromise of extraction efficiency. The main consideration with the optimization of the 
extracting volume was to avoid unnecessary metabolite dilution in the supernatant. All 
optimization studies were carried out with hydrolyzed milk samples previously spiked with pure 
OH-PAH standards at the parts-per-billion concentration level. Visual monitoring of the 
centrifugation step revealed that one minute was sufficient for residue precipitation and 
transparent supernatants well-suited for optical spectroscopy.  
Optimization of sample mixing time and volume of extracting solvent was carried out via 
RTF spectroscopy. Figure 4.1 compares the excitation and fluorescence spectra of 2OH-Flu, 
6OH-Chry, 1OH-Pyr and 3OH-B[a]P recorded from standard solutions in pure methanol and 
5/95 v/v methanol/water mixtures. All fluorescence spectra were recorded using the same 
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excitation and emission band-pass (2 nm). No attempts were made to adjust slit-widths to 
optimize spectral resolution, nor were the spectra corrected for instrumental response. Because 
the spectral profiles of the metabolites did not vary with the proportion of methanol added to the 
aqueous mixture, we monitored the concentration of each OH-PAH with a single set of 
excitation and fluorescence wavelengths. All measurements were made at the maximum 
excitation and emission wavelengths of the metabolite.  
 
 
Figure 4.1 Excitation (darker) and fluorescence (lighter) spectra recorded from 100% methanol (solid line) 
and 5-95(v/v) methanol/water (dotted line) of A: 2OH-Flu; B: 6OH-Chry; C: 1OH-Pyr; D: 3OH-B[a]P. 
All spectra recorded with the same excitation (2nm) and emission (2nm) band-pass. 
57 
 
The fluorescence intensities of the four metabolites in the supernatants increased with the 
volume of extracting solvent. This trend was common to any given period of shaking time. The 
shortest shaking time that provided the highest fluorescence intensities was 30 min. The highest 
fluorescence intensities were obtained with 1400 and 1600 μL of methanol. These two volumes 
provided statistically equivalent fluorescence intensities (α = 0.05; N1 = N2 = 3).
87
 Figure 4.2 
correlates the percentages of recovered metabolites to the volume of extracting solvent. Each 
recover plotted in the graph corresponds to the average of three determinations taken from three 
samples submitted to the entire LLE procedure. The recovery values (%R) were obtained with 
the formula: 
%R = ([OH-PAH] x VS / COH-PAH x VOH-PAH) x 100 (4.1) 
where COH-PAH and VOH-PAH are the concentration and the volume of spiked standard solution, 
respectively; and [OH-PAH] is the metabolite concentration in the volume of supernatant (VS). 
Supernatant concentrations were determined with the aid of calibration curves prepared in 
methanol-water mixtures of appropriate volume/volume compositions. The best extraction 
efficiencies were obtained with 1400 and 1600 L of methanol. These two volumes provided 
statistically equivalent extractions (= 0.05; N1 = N2 = 3).
87
 Considering the dilution of 
metabolites in the supernatants, we opted to conduct all further studies with 1400 L of 
methanol. 
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Figure 4.2 Effect of methanol volume on the percentage of recovery  (R%) of OH-PAH. 
Each recovery corresponds to the average of three determinations taken from three samples submitted to the 
entire LLE procedure. All measurements were made at the maximum excitation and emission wavelength of 
the metabolite using an excitation/emission band-pass of 2 nm. 
 
Table 4.1 reports the RTF analytical figures of merit (AFOM) obtained with 1400 L of 
extracting solvent. Calibration curves of pure standards were prepared in methanol-water 78/22 
v/v, i.e. the methanol-water proportion corresponding to 1400 L of methanol in the supernatant. 
Each calibration curve was built with a minimum of five metabolite concentrations. For each 
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concentration plotted in the calibration graph, the RTF intensity was the average of at least three 
determinations taken from three sample aliquots. No efforts were made to experimentally obtain 
the upper concentration limit of the calibration curve. The correlation coefficients of the 
calibration curves were close to unity, indicating a linear relationship between OH-PAH 
concentration and fluorescence intensity. Within the linear dynamic range (LDR) of the 
calibration curves, the relative standard deviations (RSD) at medium concentrations were lower 
than 2%. The limits of detection (LOD) were calculated using the equation LOD = 3 x SB / m; 
where SB is the standard deviation of sixteen blank determinations and m is the slope of the 
calibration curve. The limits of quantitation (LOQ) were calculated according to the formula 
LOQ = 10 x SB / m.
87
 The m values were calculated via the least squares method.
87
 At the LOQ 
concentration levels, the RSD of fluorescence measurements varied between 5 and 7%, allowing 
us to make precise measurements at low parts-per-billion concentration levels. Care was taken to 
rule out possible metabolite adhesion to the walls of the centrifugation vessels or metabolite 
precipitation in the absence of methanol, i.e. solely due to the centrifugation step. 
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Table 4.1 RTF Analytical figures of merit of OH-PAH in methanol/water (78/22 v/v) 
OH-PAH λex/em
 a
 LDR (ppb) 
b
 R
2 c
 LOD (ppb) 
d
 LOQ (ppb) 
e
 RSD (%)
 f
 
2OH-Flu 281/328 1.44 – 50 0.9986 0.436 1.448 1.31 
6OH-Chry 269/378 0.41  - 50 0.9924 0.125 0.413 0.71 
1OH-Pyr 347/387 0.24  - 50 0.9971 0.073 0.240 1.34 
3OH-B[a]P 381/432 0.21 -  50 0.9982 0.063 0.207 0.58 
a 
Maximum excitation and emission wavelength in nm. 
b
 Linear dynamic range. 
c
 Correlation 
coefficient of the calibration curve. 
d
 Limit of detection calculated as 3 SB/m; where SB is the 
standard deviation of 16 blank measurements and m is the slope of the calibration curve. 
e
 
Limit of quantification calculated as 10 SB /m. 
f
 Relative standard deviation (RSD) = SF/IF x 
100, where SF is the standard deviation of the average calculated from three RTF 
measurements at medium linear OH-PAH concentrations. 
 
 
4.3.2 Synchronous RTF spectroscopy of OH-PAH  
The synchronous excitation approach consists of varying simultaneously both the 
excitation (’) and emission () wavelengths while keeping constant a wavelength interval 
–’between them. The judicious choice of the  parameter should introduce a new 
degree of selectivity for resolving the spectral overlapping of 2OH-Flu, 6OH-Chry, 1OH-Pyr and 
3OH-B[a]P. Spectral discrimination was first attempted with wavelength offsets varying from 5 
to 120 nm, i.e. within the S0-S1 and S0-S2 absorption ranges of the studied metabolites. The best 
spectral resolution was obtained upon synchronous excitation with relatively small wavelength 
offsets ( < 10 nm). The smaller  values led to spectral simplification with narrower full-
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width at half maxima. This trend is clearly shown in Figure 4.3, which compares the 
synchronous spectra of a synthetic mixture of the four metabolites recorded withs equal to 9 
and 40 nm. Both spectra were recorded with the same excitation and emission band-pass (3 nm). 
Figure 4.4 demonstrates the effect of decreasing the  value and the instrumental band-pass on 
the spectral resolution of 6OH-Chry and 1OH-Pyr. The two peaks used for their discrimination 
appear in a different spectral region than those obtained with a  value of 9nm. Base line 
resolution of the two metabolites was only achieved under synchronous excitation with a  = 5 
nm and an excitation/emission band-pass of 1 nm. It should be noted that 2OH-Flu and 3OH-
B[a]P pose no interference to 6OH-Chry and 1OH-Pyr because their synchronous excitation 
peaks appear at 325 (2OH-Flu) and 433 nm (3OH-B[a]P).  
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Figure 4.3 Synchronous fluorescence spectra of a synthetic mixture of PAH metabolites recorded withs 
equal to 9 and 40 nm. 
Both spectra were recorded with excitation and emission band-pass equal to 3 nm. I: 15 ng.ml
-1
 2OH-Flu; II: 
25 ng.ml
-1
 6OH-Chry; III: 10 ng.ml
-1
1OH-Pyr; IV: 6 ng.ml
-1
3OH-B[a]P. 
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Figure 4.4 Normalized Synchronous Fluorescence Spectra of 6 ng.ml
-1 
6OH-Chry (II) and 2 ng.ml
-1 
1OH-Pyr 
(III). 
1:  = 7 nm, band-pass = 2 nm/2 nm; 2: Δλ = 5 nm, band-pass = 1 nm/1 nm. 
 
4.3.3 Analysis of milk samples via synchronous RTF spectroscopy  
The feasibility to monitor 2OH-Flu, 6OH-Chry, 1OH-Pyr and 3OH-B[a]P in real world 
samples was investigated with different brands of commercially available cow milk. These 
included whole milk, reduced-fat milk and fat-free milk. Possible spectral interference from 
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matrix concomitants of unknown composition was ruled out with the analysis of milk samples 
previously submitted to hydrolysis and LLE. Representative examples of synchronous spectra 
from spiked and un-spiked milk samples are provided in Figure 4.5. Potential matrix effects that 
could cause variations of signal intensities were investigated with milk samples previously 
spiked with synthetic mixtures of the four metabolites. The peak intensities recorded from the 
milk extracts were compared to those from synthetic mixtures of equivalent metabolite 
concentrations. All synthetic mixtures were prepared in methanol/water 78/22 v/v. There was no 
statistical difference in any of the analyzed samples ( = 0.05%; N1 = N2 = 3).
87
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Figure 4.5 Synchronous RTF spectra of OH-PAH extracted from milk samples of different fat content. 
Solid line: spiked sample; dotted line: un-spiked sample. I: 7 ng.ml-1 2OH-Flu; II: 13 ng.ml-1 6OH-Chry; III: 
5 ng.ml-1 1OH-Pyr; IV: 4 ng.ml-1 3OH-B[a]P. 
 
Table 4.2 reports the AFOM obtained from the analysis of milk samples via LLE-
synchronous RTF spectroscopy. Calibration curves were built with spiked milk samples 
submitted to the entire experimental procedure. Signal intensities plotted in the graph 
corresponded to the averages of three individual determinations taken from three analyzed 
samples. LDR, RSD, LOQ and LOD values were calculated as those reported in Table 4.1.
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The LOQs and LODs for 6OH-Chry and 1OH-Pyr were calculated under two sets of excitation/emission band-pass values, i.e. 
9/3/3 and 5/1/1 nm. Metabolite recoveries (%R) were calculated with the help of equation (4.1) 
 
Table 4.2 LLE-synchronous RTF spectroscopy AFOM of OH-PAH in milk samples 
OH-PAH 
Maximum 
peak 
a
 
LDR (ppb) 
b
 R
2
 
c
 LOQ (ppb) 
d
 LOD (ppb) 
e
 RSD (%) 
f
 R (%) 
g
 
2OH-Flu 325 2.25 – 50 0.995 6.75 2.25 3.7 91.9 ± 3.4 
6OH-Chry 379 8.17  - 50 0.999 
24.51 
27.93 
h
 
8.17 
9.31 
h
 
1.2 93.3 ± 1.1 
1OH-Pyr 392 0.91  - 50 0.997 
2.73 
5.94 
h
 
0.91 
1.98 
h
 
3.0 94.0 ± 2.8 
3OH-B[a]P 433 0.76 -  50 0.996 2.28 0.76 5.8 86.0 ± 5.0 
a
 Wavelength of maximum emission intensity, in nm. 
b
 Linear dynamic range lower concentration = limit of detection. 
c
 
Correlation coefficient of the calibration curve. 
d
 Limit of quantification calculated as 10 SB /m; where SB is the standard 
deviation of 16 blank measurements and m is the slope of the calibration curve. 
e
 Limit of detection calculated as 3 SB/m. 
f
 
Relative standard deviation based on average values obtained three independent extractions. 
g
 Recoveries calculated from 
three milk aliquots (N=3) submitted to the entire experimental procedure. 
h
 Δλ=5 nm; bandpass 1 nm /1 nm. 
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4.4 Conclusion 
Table 1.2 summarizes several features of previously reported methods for the analysis of 
OH-PAH in milk samples. No literature reports were found on the analysis of 6OH-Chry in milk 
samples. Comparison of literature values to the LODs in Table 4.2 places LLE-synchronous RTF 
spectroscopy at the higher end of the reported range. However, it should be noted that the LODs 
in Table 1.2 were obtained with larger volumes of milk than those in Table 4.2. As previously 
mentioned, the examination of Table 1.2 reveals scarce information on the analytical recoveries 
of OH-PAH. In comparison to the recoveries in Table 4.2, the reported recoveries are rather low. 
An additional advantage of LLE-synchronous RTF spectroscopy appears to be the relatively 
short analysis time. It should be noticed that analysis times in Table 1.2 only include 
instrumental times. The new LLE procedure reported here takes less than 35 min. Its 
implementation to the simultaneous extraction of numerous samples is straightforward due to the 
simplicity of its experimental procedure, small sample (400 L) and methanol (1.4 mL) volumes. 
Considering the additional 3 minutes per sample that it takes to perform synchronous RTF 
measurements of the LLE supernatants, we were able to analyze 10 samples of milk in a total of 
65 min. This is equivalent to less than 7 min per sample. The non-destructive nature of LLE-
synchronous RTF spectroscopy provides ample opportunity for OH-PAH confirmation via 
chromatographic techniques. Under this prospective, the determination of OH-PAH via LLE-
synchronous RTF spectroscopy appears to be a useful approach to monitor cow exposure to PAH 
contamination. 
  
68 
 
CHAPTER 5. DETERMINATION OF POLYCYCLIC AROMATIC 
HYDROCARBON METABOLITES IN MILK BY QUECHERS 
EXTRACTION AND CAPILLARY ELECTROPHORESIS 
 
5.1 Introduction 
Although RTF and SFS provides fast and sensitive OH-PAH determination with simple 
experimental procedures
35, 51, 52, 105
, the unambiguous identification of positional isomers is often 
challenged by almost identical excitation and fluorescence spectra. A valuable alternative for the 
analysis of positional isomers with overlapping spectra is CZE.
73, 106
 Research in our group has 
focused on the CZE analysis of 2OH-Flu, 2OH-Naph, 1OH-Pyr, 9OH-Phen, 3OH-B[a]P, 4-
hydroxybenzo[a]pyrene (4OH-B[a]P) and 5- hydroxybenzo[a]pyrene (5OH-B[a]P) in urine 
samples.
73, 106
 The fastest separation time – 17 min – was achieved with a 20mM borate buffer in 
methanol-water 50% volume/volume (v/v).
106
 Metabolites determination was carried out via 
ultraviolet-visible (UV-VIS) spectroscopy. The combination of SPE and on-line sample stacking 
lead to LODs ranging from 0.99 ng.mL
-1
 (3OH-B[a]P) to 8,54 ng.mL
-1
 (2OH-Naph).
106
 
Herein, we present a rapid method for the CZE determination of OH-PAH in milk 
samples. To the extent of our literature search, this is the first application of CZE to the analysis 
of OH-PAH in milk samples. The same is true for the QuEChERS (Quick, Easy, Cheap, 
Effective, Rugged and Safe) extraction technique, which had been applied to the analysis of 
antibiotics, pesticides and PAH
107-114 
but not to the extraction of OH-PAH. The separation of 
2OH-Flu, 1-hydroxynaphthalene (1OH-Naph), 2OH-Naph, 3-hydroxyphenanthrene (3OH-Phen) 
and 9OH-Phen was accomplished in approximately 4 min with a 20mM borate buffer in 
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methanol-water 15% v/v. On-line sample stacking made possible to achieve UV-VIS LODs at 
the low parts-per-billion level. The simplicity of the extraction procedure and the speed of the 
electrophoretic separation make this method a valuable alternative for the routine analysis of 
OH-PAH in milk samples. 
5.2 Materials and Methods 
5.2.1 Instrumentation 
Instrumentation for pH measurements, sample shaking and centrifugation, and CZE 
measurements was previously described in chapter 2. Electrophoretic runs were generated with 
the aid of a 61 cm × 50 μm I.D. (375 μm O.D.) fused-silica capillary (Polymicro). Its polyamide 
coating was removed with a window maker (MicroSolv-CE) to provide an UV transparent 
detection window with an approximate length of 4 mm. The center of the optical window was 
located at approximately 38 cm from the injection port. 
 
5.2.2 Reagents 
Solvents were HPLC grade and chemicals were analytical-reagent grade. Unless 
otherwise noted, Nanopure water (18 MΩ) was used throughout. OH-PAH were from Sigma-
Aldrich except 3OH-Phen which was from Toronto Research Chemicals. Supelclean
™ 
primary 
secondary amine (PSA) and Discovery
®
 DSC-18 octadecyl (C18) dispersive solid-phase 
extraction (SPE) sorbents were purchased from Sigma-Aldrich. All other chemicals were 
purchased from Fisher Scientific. 
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Stock solutions of OH-PAH were prepared by dissolving pure standards in methanol and 
were stored in the dark at 4
o
C. Their stability was monitored weekly via fluorescence 
spectroscopy for possible photo-degradation of metabolites. Spectral profiles and fluorescence 
intensities of stock solutions remained the same for a period of six months. Working solutions 
were prepared daily by serial dilution with methanol. Buffer solutions (BGE) were prepared 
daily and sonicated for 10 minutes to degas before use. 
 
Note: Use extreme caution when handling OH-PAH known to be extremely toxic. 
 
5.2.3 OH-PAH extraction and sample clean-up 
1200μL of commercially available bovine milk were spiked with micro-liters of OH-PAH 
stock solutions and allowed to equilibrate in the dark for 24 hours at room temperature. After 
adjusting the sample pH to 5 with HCL, 3 μL of β-glucuronidase type H-2 from Helix pomatia 
(MP Biomedicals, volume activity = 65 unit/μl) were added to the sample. The mixture was 
incubated at 37 °C overnight to convert glucuronide and sulfate conjugates into free OH-PAH. 
After hydrolysis, 300 μL of acetonitrile was added and the sample was shaken for 5 min at 1,400 
RPM. A mixture of 120 mg sodium chloride (NaCl) and 480 mg magnesium sulfate (MgSO4) 
was added; the sample was shaken for 1 min and subsequently centrifuged for 2 minutes at 
13,400 RPM. The upper acetonitrile phase was removed and transferred to a clean 2 mL 
polypropylene centrifuge tube containing 30 mg of PSA and 30 mg of C18. The mixture was 
shaken by vortex for 1 minute and centrifuged at 13,400 RPM for an equal period of time. An 
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aliquot of the supernatant (50 μL) was then transferred into a 300 μL vial insert for CZE 
analysis. 
 
5.3 Results and Discussion 
The five metabolites we chose for this study - 2OH-Flu, 1OH-Naph, 2OH-Naph, 3OH-
Phen and 9OH-Phen –belong to the “EPA-PAH group”, which facilitates the comparison of the 
analytical figures of merit (AFOM) of the new method to those previously reported and listed in 
Table 1.2 
 
5.3.1 Electrophoretic separation of OH-PAH 
As previously mentioned, the electrophoretic separation of OH-PAH is based on the 
difference among the individual values of their apparent electrophoretic mobility (app).
106
 The 
apparent electrophoretic mobility depends on the electro-osmotic flow (EOF) and the 
electrophoretic mobility of each metabolite (OH-PAH).  The electrophoretic mobility of each 
metabolite follows the equation OH-PAH q/r, where q is the metabolite’s charge and r its 
solvation radius.
82
 The negative charge on each metabolite depends on the fraction of dissociated 
metabolite (= [O-PAH-]/[OH-PAH]) at the experimental pH of the separation buffer. The 
value is given by the equation  = 10-pKa/10-pKa + 10-pH 83, where Ka is the metabolite’s acid 
dissociation constant at the experimental conditions of the separation.  
The choice of borate as the separation buffer was based on previous work in our lab.
106
 
Based on its working pH range (8.2 – 10.2) and the reported values of the dissociation constants 
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of 2OH-Flu, 1OH-Naph, 2OH-Naph, 3OH-Phen and 9OH-Phen (9.1 ≤ pKa ≤ 9.6)
77-79, 115
, the 
presence of borate should promote the partial dissociation of the metabolites in the separation 
capillary and force some degree of negative charge on each OH-PAH. Considering the position 
of the detector at the negative end (cathode) of the separation capillary, the detection of 2OH-
Flu, 1OH-Naph, 2OH-Naph, 3OH-Phen and 9OH-Phen should result from the predominance of 
the electro-osmotic flow over the electrophoretic mobility, i.e. app = EOF - OH-PAH. 
Since our previous work showed that the separation of positional isomers of OH-B[a]P 
was best accomplished with the use of methanol,
106
 i.e. an organic modifier capable to reduce 
EOF, we first attempted the optimization of this parameter for the separation of 2OH-Flu, 1OH-
Naph, 2OH-Naph, 3OH-Phen and 9OH-Phen. The final concentration of methanol in the 
separation buffer was varied from 0% to 20% v/v. Buffer pH was kept at 9.5, i.e. a pH value 
within the pKa range of the studied metabolites. The obtained results are shown in Figure 5.1. 
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Figure 5.1 Effect of MeOH% in the running buffer on the CE separation of a mixture of OH-PAH. 
Buffer: 20 mM borate; pH = 9.5; voltage = 30kV; temperature = 23 °C. Peaks are identified as follows: (1) 
2OH-Flu; (2) 2OH-Naph; (3) 3OH-Phen; (4) 1OH-Naph; (5) 9OH-Phen. 
 
As the percentage of methanol increases, peak resolution improves, especially in the 
cases of 1OH-Naph and 9OH-Phen. Complete resolution of the five metabolites is achieved with 
15 and 20% v/v methanol. Based on the shorter separation time, 15% v/v methanol was used in 
all further studies.  The effect of buffer pH on the app of the studied metabolites was 
investigated within the 9.5-10.2 pH range. The best results are shown in Figure 5.2. The fastest 
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separation was obtained with pH = 9.5, which also provided the best metabolites resolution. A 
summary of migration times, peak resolutions and peak efficiencies of the five metabolites with 
20mM borate, pH = 9.5 and 15% v/v methanol is presented in Table 5.1. 
 
 
Figure 5.2 Effect of buffer pH on the separation of the studied OH-PAH. 
Buffer: 20 mM borate; methanol: 15% v/v. Peak identification as in Figure 5.1. 
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Table 5.1 Migration time, peak resolution and peak efficiency of studied OH-PAH 
OH-PAH Migration time (min) 
a)
 Rs
 b)
 Efficiency
 c)
 
2OH-Flu 
3.31 ± 0.01 - 1.68 x 10
5
 
2OH-Naph 
3.50 ± 0.01 
3.00 
1.86 x 10
5
 
3OH-Phen 
3.59 ± 0.01 
1.43 
1.97 x 10
5
 
1OH-Naph 
3.68 ± 0.01 
1.60 
2.31 x 10
5
 
9OH-Phen 
3.73 ± 0.01 
1.30 
2.13 x 10
5
 
a) Values represent the average of 3 independent electrophoretic runs 
b) Resolution between peaks calculated from 2(t2-t1)/w2+w1. t1 and t2 are migration time of 
peaks 1 and 2, respectively. w1 and w2 are the widths at the base of each peak . 
c) Calculated from 5.54(tm/w0.5)
2
. tm: migration time. w0.5: width at half height of the peak.  
 
5.3.2 Sample stacking  
A usual approach for the improvement of LODs in instrumental methods is to increase 
the amount of sample. In the particular case of CZE, this approach is known as sample 
stacking.
57
 The one condition for its successful application to CZE is the use of a sample solvent 
with lower conductivity than the running buffer. Typical solvents for sample stacking include 
diluted buffers, water or pure organic solvents. The preferential accumulation of analyte ions at 
the narrow boundary that is formed between sample solvent and separation buffer minimizes 
analyte zone broadening.
56, 58
 Simply put, sample stacking allows the analyst to increase sample 
loading at no cost of separation efficiency.  
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Considering the straightforward procedure that would result from matching the sample 
injection solvent to the QuEChERS extraction solvent, we selected acetonitrile as the sample 
stacking solvent. Sample injection volume was optimized by monitoring peak intensity and 
shape as a function sample injection time. Figure 5.3 (A) shows typical plots obtained at 45 mbar 
of hydrostatic pressure. Intensity values are the averages of three independent electrophoretic 
runs. The relative standard deviations of the average peak intensities were within 1.87 (9OH-
Phen) and 4.71% (2OH-Naph). The signal intensities of the five metabolites reach maximum 
values at 60 s of sample injection time. In addition to lower signal intensities, injection times 
longer than 60 s produced substantial peak distortion. Figure 5.3 (B) compares the 
electropherograms recorded after 45 and 60 s of sample injection time. Because baseline 
resolution of 1OH-Naph and 3OH-Phen was only obtained with 45 s, this sample injection time 
was selected for all further studies.  
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Figure 5.3 (A) Peak heights of OH-PAH standards as a function of injection time; (B) Electropherograms of a 
mixture of OH-PAH using injection times of 45 (top) and 60 seconds (bottom). 
Buffer: 20 mM borate; methanol: 15% v/v; pH = 9.5. Peak identification as in Figure 5.1. 
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The advantage of sample stacking for 45 s of sample injection time is presented in Figure 
5.4, which compares the electropherogram of a synthetic mixture of OH-PAH prepared in 100% 
acetonitrile to the one from a synthetic mixture with the same metabolites concentrations 
prepared in the separation buffer, i.e. 20 mM borate, 15% v/v methanol, pH = 9.5. The CZE 
AFOM under optimum sample stacking conditions are summarized in Table 5.2. Calibration 
curves were built with standard mixtures containing known concentrations of the five 
metabolites in acetonitrile. Each linear dynamic range (LDR) is based on the average peak 
heights of at least five OH-PAH concentrations. The average peak heights plotted in the 
calibration graphs correspond to a minimum of three measurements made from triplicate aliquots 
submitted to three independent electrophoretic runs (N=9). Correlation coefficients (R), slopes 
(data not shown) and intercepts (data not shown) of the linear fittings were calculated with the 
least squares method.
87
 The R
2
 values close to unity confirm the existence of linear relationships 
in all cases. The lowest concentrations of the LDRs correspond to the LODs, which were 
calculated with the formula LOD = 3 SB/m; where SB is the standard deviation of the average 
blank signal estimated from one-fifth of the peak-to-peak noise (Np-p/5) and m is the slope of the 
calibration curve.
90
 The Np-p was measured at the base of each peak over a sufficiently wide 
region of the electropherogram. No efforts were made to reach the experimental values of the 
upper concentration limits of the calibration curves. The RSD values at medium linear 
concentrations show great reproducibility of measurements. 
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Figure 5.4 Electropherograms of two synthetic mixtures of OH-PAH prepared in acetonitrile (top) and in the 
separation buffer (bottom). 
 
Table 5.2 Analytical figures of merit of CZE analysis of OH-PAH  
OH-PAH R
2
 RSD% LDR 
a)
 (ppb) LOD (ppb) 
2OH-Flu 0.990 3.45 11.62 – 1000 11.62 
2OH-Naph 0.992 2.18 17.02 – 1000 17.02 
3OH-Phen 0.995 4.45 3.25 – 1000 3.25 
1OH-Naph 0.992 1.79 15.82 – 1000 15.82 
9OH-Phen 0.992 3.77 3.80 – 1000 3.80 
a) Linear dynamic range. 
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5.3.3 Optimization of QuEChERS extraction 
 Figure 5.5 shows the schematic diagram of the optimized QuEChERS procedure for the 
extraction of OH-PAH from milk samples. All chemicals we used in the procedure followed 
previous literature reports on the application of QuEChERS to milk samples.
110, 116
 The addition 
of NaCl and MgSO4 to the milk/acetonitrile mixture is supposed to reduce the aqueous phase and 
facilitate the partitioning of metabolites into the organic phase. NaCl and MgSO4 were added to 
the sample in the proportion stated by Anastassiades.
117
  
 
 
Figure 5.5 Schematic diagram of the optimized QuEChERS procedure. 
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The volume of milk was arbitrarily set at 1.2 mL. The volume of acetonitrile was optimized for 
best metabolite pre-concentration at no cost of extraction efficiency. The initial volume of 
acetonitrile we used in the optimization studies was 1.2 mL. This 1:1 acetonitrile/milk 
volume/volume ratio corresponded to the recommended weigh/weight proportion of acetonitrile 
and milk previously reported in the literature.
110
 Figure 5.6 compares the overall recoveries (%R) 
of the studied metabolites as a function of acetonitrile volume. Recovery values (%R) were 
obtained with the formula: %R = ([OH-PAH] x VS / COH-PAH x VOH-PAH) x 100, where COH-PAH 
and VOH-PAH were the concentration and the volume of spiked standard solution, respectively; 
and [OH-PAH] was the metabolite concentration in the volume of extracting solvent (VS). 
 
Figure 5.6 OH-PAH recoveries versus milk/acetonitrile ratios. 
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Concentrations of OH-PAH in the acetonitrile supernatant were determined via CZE with the aid 
of the calibration curves in Table 5.2. Considering the statistically equivalent recoveries (= 
0.05; N1 = N2 = 3)
116
 of the five metabolites at the four investigated ratios, we adopted a 0.3mL 
as the volume of extracting solvent. Further sample clean-up was achieved with a combination of 
C18 and PSA. C18 has been used to remove non-polar compounds such as lipids. PSA has 
shown to be effective for removing impurities such as fatty acids and sugars.
118
 The advantage of 
using a combination of the two is illustrated in Figure 5.7. 
 
 
Figure 5.7 Electropherograms of dispersive SPE clean-up optimization using PSA (top), C18 (middle) and 
C18+PSA (bottom) 
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5.3.4 QuEChERS – CZE analysis of milk samples 
The new method was tested with several brands of commercially available whole milk. 
The AFOM are summarized in Table 5.3. Calibration curves were built by spiking milk samples 
with standards mixtures of OH-PAH. Spiked samples were submitted to the entire experimental 
procedures previously described. Calibration curves consisted of a minimum of five data points. 
Signal intensities plotted in the calibration graphs correspond to the averages of three individual 
determinations taken from three analyzed samples. No efforts were made to obtain the upper 
concentration limits of the calibration curves. LODs, LDRs and RSDs were calculated as those 
reported in Table 5.2. LODs in Table 5.3 are considerably higher than those obtained via 
chromatographic methods (see Table 1.2). The poorer LODs probably result from the smaller 
volume of milk sample and the lack of a substantial pre-concentration step such as SPE and/or 
LLE. The theoretical value for the pre-concentration factor due to the QuEChERS procedure is 
equal to 4 (see Figure 5.6). Interesting to note is the good agreement of the theoretical value to 
the experimental LOD improvements due to the QuEChERS procedure. Comparison of LODs in 
Table 5.3 to those in Table 5.2 reveal LOD ratios  - i.e. LOD Table 5.2 / LOD Table 5.3 - varying from 
~ 3 (9OH-Phen) to ~ 4.6 (2OH-Naph). The RSDs via QuEChERS - CZE (see Table 5.3) are 
higher than those via CZE (see Table 5.2) but still acceptable for analytical use. The poorer 
reproducibility of measurements is probably due to the additional steps of the QuEChERS 
procedure. Metabolite recoveries were calculated as those in Figure 5.6. Unfortunately, the 
comparison of recoveries to those obtained with chromatographic methods is not possible due to 
the incomplete nature of previously reported data (see Table 1.2). The reason for the lack of 
reported data is unknown.  
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Table 5.3 QuChERS-CZE analytical figures of merit of OH-PAH in milk samples 
OH-PAH R
2
 LDR (ppb) 
a)
 LOD (ppb) RSD(%) Recovery (%) 
b)
 
2OH-Flu 0.994 2.82 – 200 2.82 5.8 95.6 ± 4.8 
2OH-Naph 0.995 3.72 – 200 3.72 4.5 105.0 ± 4.4 
3OH-Phen 0.992 0.98 – 200 0.98 7.4 83.0 ± 3.5 
1OH-Naph 0.992 3.60 – 200 3.60 4.2 104.3 ± 2.8 
9OH-Phen 0.999 1.29 – 200 1.29 4.3 80.4 ± 4.1 
a) Linear dynamic range. b) Recoveries calculated from three milk aliquots (N = 3) submitted 
to the entire experimental procedure. 
 
5.4 Conclusions 
We have presented the first application of QuEChERS – CZE to the analysis of OH-PAH in milk 
samples. Complete resolution of 2OH-Flu, 1OH-Naph, 2OH-Naph, 3OH-Phen and 9OH-Phen 
was accomplished in approximately 4 min of electrophoretic run. UV-VIS LODs at the parts-per-
billion concentration level were obtained with the aid of sample stacking. CZE analysis of 
QuEChERS extracts was facilitated with the use of a single solvent (acetonitrile) for both 
metabolite extraction and sample stacking. Although the LODs of the new method are 
considerably higher than those from chromatographic methods,
45, 46, 48, 50
 the LODs of 2OH-Flu, 
3OH-Phen and 9OH-Phen are between one and two orders of magnitude lower than their 
concentrations in milk samples of ruminants exposed to fluorene and phenanthrene. There is no 
previous data on milk concentration levels of 1OH-Naph and 2OH-Naph.  
85 
 
In comparison to chromatographic methods, an attractive feature of QuEChERS – CZE 
for screening purposes appears to be the relatively short analysis time. The small sample volume 
and the conservative usage of chemical reagents make QuEChERS extraction possible in a 2mL 
centrifuge vial. This fact facilitates the implementation of the QuEChERS procedure to the 
simultaneous extraction of numerous samples. Using a centrifuge with maximum capacity of ten 
sample vials, it is possible to process ten samples in 10 min of extraction time. Adding 4 min of 
electrophoretic run per sample, it should be possible to screen ten samples in approximately one 
hour of analysis time. The small extract volume (~ 10
-9
 L) required for CZE injection provides 
ample opportunity for further chromatographic usage and confirmation of positive samples.  The 
unique electrophoretic pattern of 1OH-Naph and 2OH-Naph as well as 3OH-Phen and 9OH-
Phen demonstrates the potential of CZE for the unambiguous determination of positional isomers 
with very similar chromatographic behaviors and undistinguishable mass fragmentation patterns. 
Considering the plethora of metabolites originating from EPA-PAH exposure, and the possible 
formation of rather large and structurally similar polar metabolites, the new method could be a 
valuable alternative for the analysis of PAH metabolites with difficult CG behavior and lengthy 
derivatization procedures. 
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CHAPTER 6. DETERMINATION OF ACID DISSOCIATION CONSTANTS 
FOR MONOHYDROXY METABOLITES OF POLYCYCLIC 
AROMATIC HYDROCARBONS BY CAPILLARY 
ELECTROPHORESIS 
 
6.1 Introduction 
Attempts to separate 1OH-Naph from 2OH-Naph in a synthetic mixture with 2OH-Flu, 
9OH-Phen, 3OH-B[a]P, 4OH-B[a]P, 5OH-B[a]P and  1OH-Pyr  using the same conditions as 
those in chapter 3 (borate buffer, 50% MeOH, pH = 9.7) were unsuccessful due to the severe 
overlapping between the two naphthalene isomers. In this chapter, we present the resolution of 
the eight metabolites under a new set of separation conditions, namely N-cyclohexyl-3-
aminopropanesulfonic acid (CAPS) buffer in 40% MeOH. The migration times of the studied 
metabolites were then used to calculate their apparent (app) and effective (OH-PAH) 
electrophoretic mobilities under the conditions of the separation. An investigation of the 
dissociation constants was then undertaken to better understand the electrophoretic behavior of 
the studied metabolites. Previous articles
77-81, 83, 115, 119-121
 provide useful information on the 
dissociation constants of PAH metabolites but their values do not reflect the actual degrees of 
metabolites dissociations under the separation conditions of our studies. The majority of the 
reports present dissociation constants obtained from aqueous mixtures of organic solvents using 
potentiometric
120
 and spectrophotometric
77-81, 83, 115, 119, 121
 data. The few articles that exist on 
CZE dissociation constants provide pKa values for only three monohydroxy-PAH, i.e. 1OH-
Naph, 1OH-Pyr and 3OH-B[a]P.
80, 83, 115
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6.2 Materials and Methods 
6.2.1 Instrumentation 
pH measurements were made with an AR-15 pH/mV/C meter and a combined electrode 
from Fischer Scientific. 
CZE measurements were carried out as described in section 2.3. The total length of the 
capillary was 82 cm (Polymicro). Its polyamide coating was removed with a window maker 
(MicroSolv-CE) to provide an UV transparent detection window with an approximate length of 2 
mm. The center of the optical window was located at approximately 58 cm from the injection 
port. Sample injection was accomplished via hydrodynamic pressure applying 50mbar for 6 s. At 
the beginning of the day, the capillary was rinsed for 10 minutes with 0.1M NaOH and 10 
minutes with the BGE. Between runs, the capillary was rinsed with 0.1M NaOH (1 min) and 
BGE (2 min). At the end of each working day, the capillary was rinsed for 10 minutes with 
methanol and 10 minutes with nanopure water to remove residual impurities.  
 
6.2.2 Reagents 
All reagents were of analytical grade and were used without further purification. Buffer 
solutions were prepared with Nanopure water (18 MΩ) and, when needed, HPLC grade methanol 
acquired from Fisher Scientific. CAPS and 3-Cyclohexylamino-2-hydroxy-1-propane sulfonic 
acid (CAPSO) buffers were purchased from Sigma. 3OH-B[a]P, 4OH-B[a]P and 5OH-B[a]P 
were acquired from MRI (Kansas City, MO).  The remaining OH-PAH were acquired from 
Aldrich.  
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6.2.3 Solution preparation 
Stock solutions of OH-PAH were prepared in HPLC grade methanol with a concentration 
of 100 mg/l. Working solutions were prepared by serial dilution of stock solutions with HPLC 
grade methanol. All solutions were kept stored in the dark at 4°C. Buffer solutions (BGE) were 
prepared daily and sonicated for 10 minutes before use. 
 
6.3 Results and Discussion 
6.3.1 Resolution of OH-PAH using CAPS buffer in 40% MeOH 
The separation of the eight metabolites was first attempted in 100% water CAPS. No 
separation was observed from any of the metabolites in the mixture. The excessively fast electro-
osmotic flow did not provide enough time for the separation to occur. Figure 6.1 shows an 
electropherogram with the separation of the eight metabolites using a 100mM CAPS buffer 
solution in 40% MeOH. Lower contents of methanol in the CAPS buffer (50 v/v) were also 
attempted but the resolution of 4OH-B[a]P and 5OH-B[a]P was not possible.  
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Figure 6.1 CZE separation of a mixture of eight OH-PAH. 
Buffer: 100mM CAPS with 40% v/v methanol, apparent pH 10.1, voltage 26kV, temperature 25ºC, injection: 
50 mbar - 9 s. Peak identification: (1) EOF marker (MeOH), (2) 2OH-Flu, (3) 2OH-Naph, (4) 1OH-Naph, (5) 
9OH-Phen, (6) 5OH-B[a]P, (7) 4 OH-B[a]P, (8) 3 OH-B[a]P, (9) 1OH-Pyr. 
 
6.3.2 Calculation of apparent and electrophoretic mobility based on migration times 
Table 6.1 correlates the migration times of OH-PAH to their apparent (app) and 
electrophoretic (OH-PAH) mobilities. The app values were calculated using equation (6.1) 
82
: 
app
 
= [L x LD / V] [1/t]     (6.1) 
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where L refers to the length of the capillary (82 cm), LD is the distance from the injection port to 
the detection window (58 cm), V is the applied voltage (26,000 volts) and t is the migration time 
of OH-PAH in seconds. The PAH values were calculated with the following equation: 
PAH = EOF - app      (6.2) 
The electro-osmotic flow mobility (EOF) was considered constant over the entire time of the 
separation. Its value (1.69 x 10
-4
 cm
2
 V
-1
 s
-1
) was calculated with equation 6.1 using the 
migration time of methanol (18.03 min). 
 
Table 6.1 Migration time and electrophoretic mobility of OH-PAH in CAPS 40% MeOH 
OH-PAH 
Migration time 
(min)
a)
 
μapp 
(10-4cm2 V-1 s-1)
b)
 
μOH-PAH 
(10-5cm2 V-1 s-1)
c)
 
2OH-Flu 22.75 ± 0.05 1.340 ± 0.003 3.51 ± 0.10 
2OH-Naph 25.11 ± 0.24 1.214 ± 0.012 4.77 ± 0.15 
1OH-Naph 26.79 ± 0.02 1.138 ± 0.001 5.53 ± 0.10 
9OH-Phen 27.69 ± 0.29 1.101 ± 0.012 5.90 ± 0.15 
5OH-B[a]P 29.79 ± 0.02 1.023 ± 0.001 6.68 ± 0.10 
4OH-B[a]P 30.33 ± 0.04 1.005 ± 0.001 6.86 ± 0.10 
3OH-B[a]P 34.43 ± 0.09 0.885 ± 0.002 8.05 ± 0.10 
1OH-Pyr 35.41 ± 0.07 0.861 ± 0.002 8.30 ± 0.15 
a) 
 
Migration time of EOF marker: 18.03 min. 
b) Apparent mobility.  
c) Effective electrophoretic mobility. 
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6.3.3 Calculation of dissociation constant values 
Determination of pKa values via CE is based on the assumption that an acid will achieve 
its maximum electrophoretic mobility when it is fully ionized. The ionized (O-PAH
-
) and 
protonated forms (HO-PAH) of PAH metabolites co-exist in the electrophoretic buffer according 
to the equilibrium OH-PAH  H+ + O-PAH-, which is described by the following equation: 
              
            
        
  (6.3) 
where γO-PAH
- and γH
+ are the activity coefficients of the ionized forms of the acid and the proton 
respectively. The activity coefficient of the neutral form OH-PAH is considered to be equal to 1. 
Keeping in mind that the effective electrophoretic mobility of the PAH metabolite can be 
calculated as follows: 
         
    
 
(
 
 
 
 
   
)     (6.4) 
where L refers to the length of the capillary, LD is the distance from the injection port to the 
detection window, V is the applied voltage, t is the migration time of the metabolite, and teo is 
the migration time of a neutral marker,
80
 in our case methanol, the above equations lead to the 
following derived linear equation
83
:  
 
       
  
    
         
 
 
       
    (6.5) 
where μO-PAH
-
 is the mobility of the fully ionized species. Ka can then be determined calculating 
the slope of the plot 1/μOH-PAH versus [H
+
]. 
 μOH-PAH were calculated with equation (6.4) by monitoring OH-PAH migration times at 
different pH values using the buffer conditions of the separation (100mM CAPS, 40%MeOH). 
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Mobilities were evaluated every 0.15 – 0.2 pH units in the pH range 8.9<pH<10.6 keeping a 
constant ionic strength of 0.03M with NaCl. OH-PAH pKa values were then obtained from the 
slope of the plot 1/μOH-PAH versus [H
+
] as described in equation (6.5). 
Figure 6.2 shows an example of a typical set of experimental results. The migration times 
of all the studied metabolites increased with the pH of the separation buffer. All the 1/OH-PAH 
versus [H
+
] plots showed a linear behavior with correlation coefficients close to unity. 
 
 
 
Figure 6.2 Electropherograms of 2OH-Flu at three different pH (left) and Plot of 1/μOH-PAH versus [H
+
] for 
2OH-Flu (right). 
EOF marker: MeOH, buffer: 100mM CAPS; temperature: 25ºC; voltage: 26 kV (EOF markers are 
intentionally matched). 
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Table 6.2 lists pKa, values, and mobilities in 40% MeOH CAPS buffer at the 
experimental pH (10.1) of our separation (see Section 6.3.1). The values were calculated with 
the use of equation
83
: 
  
      
            
      (6.6) 
 
μOH-PAH and mobilities of the fully ionized species (μOH-PAH
-
) were calculated from the plot of 
equation (6.5) at pH=10.1. Standard deviations of μOH-PAH (SμOH-PAH) and μO-PAH
-
 (SμO-PAH
-
) 
were calculated from the standard deviations of the slope (Sm) and intercept (Sb) of the plot of 
1/μOH-PAH versus [H
+
] (N=3). Standard deviations of α values (Sα) were calculated as                  
Sα / α = [(SμOH-PAH / μOH-PAH)
2
 + (SμO-PAH
-
 / μO-PAH
-
)
2
]
1/2
. 
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Table 6.2 pKa, α values and mobilities of OH-PAH determined in 40% MeOH CAPS buffer 
OH-PAH pKa 
μ
OPAH-
 
(10
-4
cm
2
 V
-1
 s
-1
) 
α a) 
μ
OH-PAH 
b) 
(10
-5
cm
2
 V
-1
 s
-1
) 
2OH-Flu 10.32 ± 0.08 0.975 ± 0.164 0.376 ± 0.069 3.67 ± 0.27 
2OH-Naph 10.29 ± 0.06 1.278 ± 0.190 0.391 ± 0.064 5.00 ± 0.34 
1OH-Naph 10.23 ± 0.07 1.370 ± 0.188 0.424 ± 0.065 5.81 ± 0.39 
9OH-Phen 10.06 ± 0.05 1.192 ± 0.111 0.522 ± 0.057 6.22 ± 0.35 
5OH-B[a]P 9.82 ± 0.04 1.077 ± 0.063 0.657 ± 0.048 7.07 ± 0.31 
4OH-B[a]P 9.78 ± 0.04 1.074 ± 0.056 0.676 ± 0.045 7.26 ± 0.29 
3OH-B[a]P 9.55 ± 0.03 1.099 ± 0.037 0.781 ± 0.035 8.59 ± 0.26 
1OH-Pyr 9.66 ± 0.03 1.207 ± 0.050 0.733 ± 0.040 8.84 ± 0.31 
a)
 Alpha values calculated with equation (6.6) at pH=10.1; 
b)
 μ
OH-PAH 
values calculated with 
equation (6.5) at pH=10.1 
 
Comparison of μOH-PAH values obtained with equation (6.5) (Table 6.2) to those 
calculated from migration times in Table 6.1 shows statistical equivalence (= 0.05; N1 = N2 = 
3).
87
 This is not surprising since the range of pH that was used to obtain μOH-PAH values from 
Table 6.2 includes the pH (10.1) at which μOH-PAH values in Table 6.1 were calculated. 
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6.4 Conclusion 
The complete separation of 8 OH-PAH, namely 2OH-Flu, 1OH-Naph, 2OH-Naph, 9OH-
Phen, 1OH-Pyr, 3OH-B[a]P, 4OH-B[a]P and 5OH-B[a]P is achieved via CZE using a 40% 
methanol CAPS buffer. This OH-PAH separation could not be completed using a buffer system 
like the one described in chapter 3 due to significant overlapping of peaks belonging to 1OH-
Naph and 2OH-Naph. Electrophoretic parameters describing the migration of OH-PAH in the 
conditions of the separation were determined. Using the obtained values, it was possible to better 
understand the behavior of some PAH metabolites in the separation.  
Upon close examination of Table 6.2 several observations can be made regarding specific 
cases of OH-PAH migration in the separation presented in section 6.3.1. 2OH-Flu and 2OH-
Naph have very similar pKa and alpha values. Despite this fact, their peaks are very well 
resolved in the electropherograms. This is explained by the rather large difference between their 
μOH-PAH that causes separation. Keeping in mind equation 1.1, this variation in their μOH-PAH is a 
direct consequence of their difference in mass. Difference in migration times of 1OH-Naph and 
2OH-Naph was surprisingly large even though their alpha values are similar and they have 
equivalent molecular weights. Considering that the mass of naphthols is relatively small 
compared with the rest of OH-PAH, the effect of a small change in ionization seems to cause a 
significant variation of their μOH-PAH facilitating their separation. Another case of metabolites 
with similar alpha values is the one of 4OH-B[a]P and 5OH-B[a]P. In the case of the OH-B[a]P 
isomers, given their larger mass, a small Δα does not cause such a significant difference in their 
μOH-PAH, but it is enough as to have baseline resolution of the analyte peaks (see Figure 6.1).  
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CHAPTER 7. OVERALL CONCLUSION  
 
The development of screening methods for the analysis of OH-PAH in urine and milk 
samples has been accomplished with the aid of CZE and SFS. Optimized procedures for the 
extraction and pre-concentration of metabolites have been developed to interface SPE, LLE 
and/or QuEChERS with CZE and/or SFS. A CZE method was first developed for the analysis of 
urine samples achieving baseline resolution of 2OH-Flu, 2OH-Naph, 9OH-Phen, 1OH-Pyr, 
3OH-B[a]P, 4OH-B[a]P and 5OH-B[a]P in approximately 17 min. The separation buffer 
consisted of 20mM borate in 50% methanol-water (volume/volume). Competitive limits of 
detection were obtained for all the studied metabolites using commercial instrumentation 
equipped with an UV-VIS absorption detector. Detection at the sub-parts-per-billion 
concentration levels was made possible via sample pre-concentration based on SPE and sample 
stacking.  SPE was performed with the aid of a twelve port vacuum manifold. Sample stacking 
was made in methanol, i.e. the eluting solvent from the SPE procedure. Metabolite recoveries 
varied from 93.2 ± 7.7% (5OH-B[a]P) to 108.7 ± 7.8% (2OH-Naph). LODs were at the trace 
level ranging from 0.99 ng.mL
-1 
(3OH-B[a]P) to 8.54 ng.mL
-1
 (2OH-Naph). The new method 
was found to be free of interference from four pharmacological drugs - naproxen, ibuprofen, 
diclofenac and amoxicillin – that might be found in urine samples of unhealthy individuals. 
The analysis of OH-PAH in milk samples was first attempted via SFS. Metabolites were 
extracted form milk samples with a two-step LLE procedure. Quantitative analysis was carried 
out in the sample extract without the need of previous chromatographic separation. Excellent 
recoveries and LODs at the parts-per-billion level were obtained for 2OH-Flu, 6OH-Chry, 1OH-
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Pyr and 3OH-B[a]P. The small sample (400 L) and extracting solvent (1.4 mL) volumes 
facilitates the simultaneous extraction of numerous samples via an environmentally friendly 
procedure, which is well-suited for routine monitoring of numerous samples. The non-
destructive nature of the new method provides ample opportunity for metabolite confirmation via 
chromatographic techniques. 
 The main drawback of SFS is its inability to differentiate among positional isomers with 
almost identical excitation and fluorescence spectra. A CZE method was then developed for the 
complete resolution of 2OH-Flu, 1OH-Naph, 2OH-Naph, 3OH-Phen and 9OH-Phen in 
approximately 4 min of electrophoretic run. Metabolites extraction and pre-concentration was 
accomplished with an optimized QuEChERS procedure. LODs at the parts-per-billion level were 
obtained using a single solvent (acetonitrile) for metabolite extraction and sample stacking. The 
small sample volume (1.2 mL) and the conservative usage of chemicals provided a simple and 
rapid procedure for the simultaneous extraction of numerous samples. Adding 4 min of 
electrophoretic run per sample, it should be possible to screen ten samples in approximately one 
hour of analysis time. The nanoliter extract volume required for sample injection allows for 
further chromatographic usage and confirmation of positive samples. 
Attempts to separate 1OH-Naph from 2OH-Naph in a synthetic mixture with 2OH-Flu, 
9OH-Phen, 3OH-B[a]P, 4OH-B[a]P, 5OH-B[a]P and  1OH-Pyr  using borate buffer, 50% 
MeOH, pH = 9.7 were unsuccessful due to the severe overlapping between the two naphthalene 
isomers. The complete resolution of the eight metabolites was then obtained using CAPS buffer 
in 40% MeOH. An investigation of their dissociation constants was then undertaken to better 
understand the electrophoretic behavior of the studied metabolites. This was the first step to 
future work in our lab, which will focus on the rational development of CZE methodology for 
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the analysis of positional isomers with very similar chromatographic behaviors and 
undistinguishable mass fragmentation patterns. 
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APPENDIX A: EXCITATION AND FLUORESCENCE SPECTRA OF THE 
STUDIED METABOLITES IN PERTINENT SOLVENTS 
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Figure A-1 Room temperature excitation and fluorescence spectra of 2OH-Flu 100 ppb in 
methanol 
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Figure A-2 Room temperature excitation and fluorescence spectra of 2OH-Flu 100 ppb in 
methanol/water 0.05% v/v 
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Figure A-3 Room temperature excitation and fluorescence spectra of 2OH-Naph 100 ppb in 
methanol 
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Figure A-4 Room temperature excitation and fluorescence spectra of 2OH-Naph 200 ppb in 
methanol/water 0.05% v/v 
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Figure A-5 Room temperature excitation and fluorescence spectra of 9OH-Phen 100 ppb in 
methanol 
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Figure A-6 Room temperature excitation and fluorescence spectra of 9OH-Phen 200 ppb in 
methanol/water 0.05% v/v 
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Figure A-7 Room temperature excitation and fluorescence spectra of 1OH-Pyr 50 ppb in 
methanol 
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Figure A-8 Room temperature excitation and fluorescence spectra of 1OH-Pyr 50 ppb in 
methanol/water 0.05% v/v 
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Figure A-9 Room temperature excitation and fluorescence spectra of 3OH-B[a]P 50 ppb in 
methanol 
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Figure A-10 Room temperature excitation and fluorescence spectra of 3OH-B[a]P 50 ppb 
in methanol/water 0.05% v/v 
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Figure A-11 Room temperature excitation and fluorescence spectra of 4OH-B[a]P 100 ppb 
in methanol 
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Figure A-12 Room temperature excitation and fluorescence spectra of 4OH-B[a]P 100 ppb 
in methanol/water 0.05% v/v 
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Figure A-13 Room temperature excitation and fluorescence spectra of 5OH-B[a]P 100 ppb 
in methanol 
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Figure A-14 Room temperature excitation and fluorescence spectra of 5OH-B[a]P 100 ppb 
in methanol/water 0.05% v/v 
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Figure A-15 Room temperature excitation and fluorescence spectra of 2OH-Flu 150 ppb in 
methanol/water 78/22% v/v 
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Figure A-16 Room temperature excitation and fluorescence spectra of 6OH-Chry 50 ppb in 
methanol/water 78/22% v/v 
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Figure A-17 Room temperature excitation and fluorescence spectra of 1OH-Pyr 50 ppb in 
methanol/water 78/22% v/v 
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Figure A-18 Room temperature excitation and fluorescence spectra of 3OH-B[a]P 50 ppb 
in methanol/water 78/22% v/v  
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APPENDIX B: ABSORPTION SPECTRA OF OH-PAH IN THE 
SEPARATION BUFFERS 
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Figure B-1 UV-vis absorption spectra of 2OH-Flu 3ppm in 20mM borate buffer, 50% v/v 
methanol, pH=9.7 
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Figure B-2 UV-vis absorption spectra of 2OH-Naph 6ppm in 20mM borate buffer, 50% v/v 
methanol, pH=9.7 
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Figure B-3 UV-vis absorption spectra of 9OH-Phen 3ppm in 20mM borate buffer, 50% v/v 
methanol, pH=9.7 
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Figure B-4 UV-vis absorption spectra of 1OH-Pyr 3ppm in 20mM borate buffer, 50% v/v 
methanol, pH=9.7 
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Figure B-5 UV-vis absorption spectra of 3OH-B[a]P 3ppm in 20mM borate buffer, 50% v/v 
methanol, pH=9.7 
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Figure B-6 UV-vis absorption spectra of 4OH-B[a]P 3ppm in 20mM borate buffer, 50% v/v 
methanol, pH=9.7 
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Figure B-7 UV-vis absorption spectra of 5OH-B[a]P 3ppm in 20mM borate buffer, 50% v/v 
methanol, pH=9.7 
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Figure B-8 UV-vis absorption spectra of 2OH-Flu 3ppm in 20mM borate buffer, 15% v/v 
methanol, pH=9.5 
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Figure B-9 UV-vis absorption spectra of 2OH-Naph 6ppm in 20mM borate buffer, 15% v/v 
methanol, pH=9.5 
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Figure B-10 UV-vis absorption spectra of 1OH-Naph 3ppm in 20mM borate buffer, 15% 
v/v methanol, pH=9.5 
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Figure B-11 UV-vis absorption spectra of 3OH-Phen 3ppm in 20mM borate buffer, 15% 
v/v methanol, pH=9.5 
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Figure B-12 UV-vis absorption spectra of 9OH-Phen 3ppm in 20mM borate buffer, 15% 
v/v methanol, pH=9.5 
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Figure B-13 UV-vis absorption spectra of 2OH-Flu 3ppm in 100mM CAPS buffer, 40% v/v 
methanol, pH=10.1 
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Figure B-14 UV-vis absorption spectra of 2OH-Naph 6ppm in 100mM CAPS buffer, 40% 
v/v methanol, pH=10.1 
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Figure B-14 UV-vis absorption spectra of 1OH-Naph 3ppm in 100mM CAPS buffer, 40% 
v/v methanol, pH=10.1 
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Figure B-15 UV-vis absorption spectra of 9OH-Phen 3ppm in 100mM CAPS buffer, 40% 
v/v methanol, pH=10.1 
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Figure B-16 UV-vis absorption spectra of 1OH-Pyr 3ppm in 100mM CAPS buffer, 40% v/v 
methanol, pH=10.1 
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Figure B-17 UV-vis absorption spectra of 3OH-B[a]P 3ppm in 100mM CAPS buffer, 40% 
v/v methanol, pH=10.1 
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Figure B-18 UV-vis absorption spectra of 4OH-B[a]P 3ppm in 100mM CAPS buffer, 40% 
v/v methanol, pH=10.1 
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Figure B-19 UV-vis absorption spectra of 5OH-B[a]P 3ppm in 100mM CAPS buffer, 40% 
v/v methanol, pH=10.1 
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APPENDIX C: PLOTS OF 1/μOH-PAH VERSUS [H
+
] USED FOR 
DETERMINATION OF PKA VALUES 
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Figure C-1 Plot of 1/μOH-PAH versus [H
+
] for 2OH-Naph in 100mM CAPS buffer, 40% v/v 
methanol, pH=10.1 
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Figure C-2 Plot of 1/μOH-PAH versus [H
+
] for 1OH-Naph in 100mM CAPS buffer, 40% v/v 
methanol, pH=10.1 
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Figure C-3 Plot of 1/μOH-PAH versus [H
+
] for 9OH-Phen in 100mM CAPS buffer, 40% v/v 
methanol, pH=10.1 
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Figure C-4 Plot of 1/μOH-PAH versus [H
+
] for 1OH-Pyr in 100mM CAPS buffer, 40% v/v 
methanol, pH=10.1 
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Figure C-5 Plot of 1/μOH-PAH versus [H
+
] for 3OH-B[a]P in 100mM CAPS buffer, 40% v/v 
methanol, pH=10.1 
0.00E+000 5.00E-011 1.00E-010 1.50E-010 2.00E-010 2.50E-010 3.00E-010
10000
12000
14000
16000
18000
20000
22000
24000


O
H
-P
A
H
[H
+
]
 
Figure C-6 Plot of 1/μOH-PAH versus [H
+
] for 4OH-B[a]P in 100mM CAPS buffer, 40% v/v 
methanol, pH=10.1 
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Figure C-7 Plot of 1/μOH-PAH versus [H
+
] for 5OH-B[a]P in 100mM CAPS buffer, 40% v/v 
methanol, pH=10.1 
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